<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Topical NSAIDs for acute musculoskeletal pain in adults - Derry, S - 2015 | Cochrane Library</title> <meta content="Topical NSAIDs for acute musculoskeletal pain in adults - Derry, S - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007402.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Topical NSAIDs for acute musculoskeletal pain in adults - Derry, S - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007402.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007402.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Topical NSAIDs for acute musculoskeletal pain in adults" name="citation_title"/> <meta content="Sheena Derry" name="citation_author"/> <meta content="sheena.derry@retired.ox.ac.uk" name="citation_author_email"/> <meta content="R Andrew Moore" name="citation_author"/> <meta content="Helen Gaskell" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Mairead McIntyre" name="citation_author"/> <meta content="West Hoe Surgery" name="citation_author_institution"/> <meta content="Philip J Wiffen" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD007402.pub3" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/06/15" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007402.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007402.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007402.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Pain [*drug therapy, etiology]; Administration, Topical; Anti‐Inflammatory Agents, Non‐Steroidal [*administration &amp; dosage, adverse effects]; Athletic Injuries [complications]; Musculoskeletal Pain [*drug therapy, etiology]; Randomized Controlled Trials as Topic; Sprains and Strains [complications]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007402.pub3&amp;doi=10.1002/14651858.CD007402.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="7a2tKMcJ";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007402\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007402\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ms","hr","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007402.pub3",title:"Topical NSAIDs for acute musculoskeletal pain in adults",firstPublishedDate:"Jun 15, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pain, Palliative and Supportive Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7a2tKMcJ&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007402.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007402.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007402.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007402.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007402.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007402.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007402.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007402.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007402.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007402.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>20518 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007402.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-sec-0101"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-sec-0029"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-sec-0030"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-sec-0053"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-sec-0095"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/appendices#CD007402-sec-0114"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/table_n/CD007402StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/table_n/CD007402StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Topical NSAIDs for acute musculoskeletal pain in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/information#CD007402-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Sheena Derry</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/information#CD007402-cr-0003">R Andrew Moore</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/information#CD007402-cr-0004">Helen Gaskell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/information#CD007402-cr-0005">Mairead McIntyre</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007402.pub3/information#CD007402-cr-0006">Philip J Wiffen</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/information/en#CD007402-sec-0138">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 15 June 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007402.pub3">https://doi.org/10.1002/14651858.CD007402.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007402-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007402-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007402-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007402-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007402-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007402-abs-0001" lang="en"> <section id="CD007402-sec-0001"> <h3 class="title" id="CD007402-sec-0001">Background</h3> <p>Use of topical NSAIDs to treat acute musculoskeletal conditions has become widely accepted because they can provide pain relief without associated systemic adverse events. This review is an update of 'Topical NSAIDs for acute pain in adults' originally published in Issue 6, 2010. </p> </section> <section id="CD007402-sec-0002"> <h3 class="title" id="CD007402-sec-0002">Objectives</h3> <p>To determine the efficacy and safety of topically applied NSAIDs in acute musculoskeletal pain in adults. </p> </section> <section id="CD007402-sec-0003"> <h3 class="title" id="CD007402-sec-0003">Search methods</h3> <p>We searched the Cochrane Register of Studies Online, MEDLINE, and EMBASE to February 2015. We sought unpublished studies by asking personal contacts and searching online clinical trial registers and manufacturers websites. For the earlier review, we also searched our own in‐house database and contacted manufacturers. </p> </section> <section id="CD007402-sec-0004"> <h3 class="title" id="CD007402-sec-0004">Selection criteria</h3> <p>We included randomised, double‐blind, active or placebo (inert carrier)‐controlled trials in which treatments were administered to adults with acute pain resulting from strains, sprains or sports or overuse‐type injuries (twisted ankle, for instance). There had to be at least 10 participants in each treatment arm, with application of treatment at least once daily. </p> </section> <section id="CD007402-sec-0005"> <h3 class="title" id="CD007402-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed studies for inclusion, and extracted data. We used numbers of participants achieving each outcome to calculate the risk ratio and numbers needed to treat for an additional beneficial outcome (NNT) or additional harmful outcome (NNH) compared with placebo or other active treatment. We reported 95% confidence intervals (CI). We were particularly interested to compare different formulations (gel, cream, plaster) of individual NSAIDs. </p> </section> <section id="CD007402-sec-0006"> <h3 class="title" id="CD007402-sec-0006">Main results</h3> <p>For this update we added 14 new included studies (3489 participants), and excluded four studies. We also identified 20 additional reports of completed or ongoing studies that have not been published in full. The earlier review included 47 studies. </p> <p>This update included 61 studies. Most compared topical NSAIDs in the form of a gel, spray, or cream with a similar topical placebo; 5311 participants were treated with a topical NSAID, 3470 with placebo, and 220 with an oral NSAID. This was a 63% increase in the number of included participants over the previous version of this review. We also identified a number of studies in clinical trial registries with unavailable results amounting to about 5900 participants for efficacy and 5300 for adverse events. </p> <p>Formulations of topical diclofenac, ibuprofen, ketoprofen, piroxicam, and indomethacin demonstrated significantly higher rates of clinical success (more participants with at least 50% pain relief) than matching topical placebo (moderate or high quality data). Benzydamine did not. Three drug and formulation combinations had NNTs for clinical success below 4. For diclofenac, the Emulgel® formulation had the lowest NNT of 1.8 (95% CI 1.5 to 2.1) in two studies using at least 50% pain intensity reduction as the outcome. Diclofenac plasters other than Flector® also had a low NNT of 3.2 (2.6 to 4.2) based on good or excellent responses in some studies. Ketoprofen gel had an NNT of 2.5 (2.0 to 3.4), from five studies in the 1980s, some with less well defined outcomes. Ibuprofen gel had an NNT of 3.9 (2.7 to 6.7) from two studies with outcomes of marked improvement or complete remission. All other drug and formulation combinations had NNT values above 4, indicating lesser efficacy. </p> <p>There were insufficient data to compare reliably individual topical NSAIDs with each other or the same oral NSAID. </p> <p>Local skin reactions were generally mild and transient, and did not differ from placebo (high quality data). There were very few systemic adverse events (high quality data) or withdrawals due to adverse events (low quality data). </p> </section> <section id="CD007402-sec-0007"> <h3 class="title" id="CD007402-sec-0007">Authors' conclusions</h3> <p>Topical NSAIDs provided good levels of pain relief in acute conditions such as sprains, strains and overuse injuries, probably similar to that provided by oral NSAIDs. Gel formulations of diclofenac (as Emugel®), ibuprofen, and ketoprofen, and some diclofenac patches, provided the best effects. Adverse events were usually minimal. </p> <p>Since the last version of this review, the new included studies have provided additional information. In particular, information on topical diclofenac is greatly expanded. The present review supports the previous review in concluding that topical NSAIDs are effective in providing pain relief, and goes further to demonstrate that certain formulations, mainly gel formulations of diclofenac, ibuprofen, and ketoprofen, provide the best results. Large amounts of unpublished data have been identified, and this could influence results in updates of this review. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007402-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007402-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD007402-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD007402-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007402-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007402-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD007402-abs-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007402-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD007402-abs-0006">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007402-abs-0004" lang="en"> <h3>Topical non‐steroidal anti‐inflammatory drugs for acute musculoskeletal pain in adults</h3> <p>Acute musculoskeletal pain describes conditions like a sprained ankle or a muscle pull. These usually get better over two or three weeks without treatment, but can be very painful while they last. </p> <p>Topical non‐steroidal anti‐inflammatory drugs (NSAIDs) are applied to unbroken skin where it hurts as gels, creams, sprays, or plasters. Topical NSAIDs penetrate the skin, enter tissues or joints, and reduce processes causing pain in the tissue. Drug levels in the blood with topical NSAIDs are very much lower than with the same drug taken by mouth. This minimises the risk of harmful effects. </p> <p>We searched medical databases for clinical trials comparing topical NSAIDs with placebo (creams or gels that do not contain a medicine) or other medicines in adults aged 16 years or older with musculoskeletal pain (typically sports injuries). The evidence is current to February 2015. </p> <p>This review is an update of 'Topical NSAIDs for acute pain in adults' originally published in Issue 6, 2010. We identified 14 new studies to add to the 47 studies included in the earlier review. We also identified 14 studies in a clinical trial registry that are completed and three short reports from meetings, for which we could not find full details (about 4500 participants). Three more studies are ongoing (almost 900 participants). </p> <p>The 61 included studies, involving 8386 participants, were generally of high‐quality. They tested a number of different topical drugs, mostly against a topical placebo (carrier without the NSAID), with application at least once a day. We were interested in participants having good pain reduction (by about half) around seven days after treatment started. At later times, most people are expected to get better even without treatment. </p> <p>We looked at particular formulations of individual drugs. Gel formulations of diclofenac and ketoprofen were among the most effective, along with ibuprofen gel and diclofenac plaster. For diclofenac and ketoprofen gels, 7 or 8 people out of 10 with a painful strain, sprain, or muscle pull had much reduced pain after seven days, compared with only 2 or 3 out of 10 with placebo (high quality data). Other NSAIDs and formulations were better than placebo, but not by as much. Because both topical NSAIDs and topical placebo are rubbed into the skin in these studies, we know that any effect is not just from rubbing. </p> <p>About 1 in 20 people experienced a mild and short‐lived side effect like redness at the application site. This was the same for topical NSAID and topical placebo (high quality data). Side effects like a stomach upset or feeling sick were uncommon, with no difference between topical NSAID and topical placebo (high quality data). There were no serious side effects. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007402-sec-0101" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007402-sec-0101"></div> <h3 class="title" id="CD007402-sec-0102">Implications for practice</h3> <section id="CD007402-sec-0102"> <section id="CD007402-sec-0103"> <h5 class="title">For people with acute musculoskeletal pain</h5> <p>Topical NSAIDs can provide good levels of pain relief in acute conditions such as sprains, strains, and overuse injuries, probably similar to that provided by oral NSAIDs. Gel formulations of diclofenac (as Emulgel®), ibuprofen, and ketoprofen, and some diclofenac patches provide the best effects. Adverse events are usually minimal with topical NSAIDs. </p> </section> <section id="CD007402-sec-0104"> <h5 class="title">For clinicians</h5> <p>Topical diclofenac, ibuprofen, or ketoprofen gels provide good pain relief for painful acute musculoskeletal conditions and are better tolerated than oral formulations. These drugs and formulations are more likely to be cost effective than alternative topical preparations such as topical rubefacients. </p> </section> <section id="CD007402-sec-0105"> <h5 class="title">For policy makers</h5> <p>Topical NSAIDs are not associated with an increased incidence of local skin reactions compared with the inert carrier, and while the carrier may cause mild, transient irritation, it is rarely troublesome. Topical NSAIDs do not cause systemic (mainly gastrointestinal) problems commonly seen with oral NSAIDs, making them particularly useful for individuals unable to tolerate oral administration, or for whom it is contraindicated. </p> </section> <section id="CD007402-sec-0106"> <h5 class="title">For funders</h5> <p>Topical diclofenac, ibuprofen, or ketoprofen gels should be considered for initial treatment of acute musculoskeletal painful conditions where there are no contraindications, such as damaged skin. These drugs and formulations are more likely to be cost effective than alternative topical preparations such as topical rubefacients. </p> <p>Because formulations of topical NSAIDs are likely to change over time, the relevant trials performed and reported in or before the 1990s must be limited and may be questionable. Funders might wish to consider asking pharmaceutical companies without recent trial evidence for their products to produce it. </p> </section> </section> <h3 class="title" id="CD007402-sec-0107">Implications for research</h3> <section id="CD007402-sec-0107"> <section id="CD007402-sec-0108"> <h5 class="title">General</h5> <p>The general thrust of these findings is that gel formulations of topical diclofenac, ibuprofen, and ketoprofen work best, but for some drugs (ketoprofen, for instance) studies were pre‐1990. These studies may not be relevant to products available now. Because formulation can have a significant effect on efficacy, formulation changes should be accompanied by relevant randomised trials. </p> </section> <section id="CD007402-sec-0109"> <h5 class="title">Design</h5> <p>The design of the trials is generally good, and the sports injury model appears to be reliable and reproducible. Modern studies have ensured that participants entering the trials have at least moderate pain, and this helps sensitivity to detect an analgesic response. Major changes to the design of these trials would not appear to be needed. </p> </section> <section id="CD007402-sec-0110"> <h5 class="title">Measurement (endpoints)</h5> <p>A major issue is not in the measurement of pain, as most studies, especially modern studies, have used standard pain intensity and pain relief scales. However, reporting of average pain changes is inadequate, and the use of responder analyses (at least 50% pain intensity reduction, or people experiencing mild or no pain) is preferred. </p> </section> <section id="CD007402-sec-0111"> <h5 class="title">Comparison between active treatments</h5> <p>Indirect comparisons with placebo are probably as informative as use of an active comparator. </p> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007402-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007402-sec-0022"></div> <div class="table" id="CD007402-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Topical NSAIDs compared with topical placebo for acute musculoskeletal pain in adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Topical NSAIDs compared with topical placebo for acute musculoskeletal pain in adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with strains, sprains, or muscle pull </p> <p><b>Settings:</b> community </p> <p><b>Intervention:</b> topical NSAID (topical diclofenac, ibuprofen, and ketoprofen gels only shown here for efficacy) </p> <p><b>Comparison:</b> topical placebo </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probable outcome with<br/> intervention</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probable outcome with<br/> comparator</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>RR, NNT, NNTp, or NNH<br/> (95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of studies, participants</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Topical diclofenac gel (as Emulgel)</b> </p> <p><b>Clinical success (eg 50% reduction in pain)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>780 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR</p> <p>3.4 (2.7 to 55)</p> <p>NNT</p> <p>1.8 (1.5 to 2.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 studies</p> <p>314 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Consistent results in 2 moderately sized recent studies of high quality</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Topical ibuprofen gel</b> </p> <p><b>Clinical success (eg 50% reduction in pain)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>420 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>160 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR</p> <p>2.7 (1.7 to 4.2)</p> <p>NNT</p> <p>3.9 (2.7 to 6.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 studies</p> <p>241 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modest effect size and numbers of participants</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Topical ketoprofen gel</b> </p> <p><b>Clinical success (eg 50% reduction in pain)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>720 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>330 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR</p> <p>2.2 (1.7 to 2.8)</p> <p>NNT</p> <p>2.5 (2.0 to 3.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 studies</p> <p>348 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modest effect size and numbers of participants, but studies small, with none recent</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All topical NSAIDs</b> </p> <p><b>Local adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR</p> <p>1.0 (0.80 to 1.2)</p> <p>NNH not calculated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42 studies</p> <p>6125 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Large number of studies and participants with consistent results</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All topical NSAIDs</b> </p> <p><b>Systemic adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR</p> <p>1.0 (0.7 to 1.3)</p> <p>NNH not calculated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38 studies</p> <p>5372 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Large number of studies and participants with consistent results</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All topical NSAIDs</b> </p> <p><b>Withdrawals ‐ adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR</p> <p>1.0 (0.7 to 1.7)</p> <p>NNH not calculated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42 studies</p> <p>5790 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Large number of studies and participants with consistent results</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serious adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 in total</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 in total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Small numbers of events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>CI: confidence interval; RR: risk ratio; NNT: number needed to treat for an additional beneficial outcome; NNTp: number needed to treat to prevent an event happening; NNH: number needed to treat for an additional harmful outcome. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007402-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007402-sec-0023"></div> <p>This review is an update of a review originally published in Issue 6 2010 on 'Topical NSAIDs for acute pain in adults' (<a href="./references#CD007402-bbs2-0148" title="MasseyT , DerryS , MooreRA , McQuayHJ . Topical NSAIDs for acute pain in adults. Cochrane Database of Systematic Reviews2010, Issue 6. [DOI: 10.1002/14651858.CD007402.pub2] ">Massey 2010</a>). We have changed the title to specify musculoskeletal pain because topical NSAIDs are not normally used to treat visceral pain or headache. We felt that the new title better reflected the content of the review. </p> <p>The use of topical NSAIDs for pain relief has been a controversial subject in analgesic practice. In some parts of the world (including much of Western Europe) they have been available for many years, are widely available without prescription, widely advertised, used extensively, and evidence for their use is considered adequate. In other parts of the world they were regarded as little more than placebo, with any apparent effect attributed to the process of rubbing at the site of the affected area. In some places (for example the US) their use was almost unknown until the mid‐2010s. In England, 5.2 million prescriptions for topical NSAIDs were dispensed in 2013 (<a href="./references#CD007402-bbs2-0140" title="Prescribing and Primary Care team, Health and Social Care Information Centre. Prescrption Cost Analysis, England 2013. Health and Social Care Information Centre. The NHS Information Centre, 2014:298‐301. [ISBN: 978‐1‐78386‐089‐0] ">PACT 2014</a>), mainly for formulations of ibuprofen (2.45 million), piroxicam (1.18 million), and diclofenac (1.27 million). </p> <p>There is good evidence for the efficacy of topical NSAIDs in acute and chronic musculoskeletal pain (<a href="./references#CD007402-bbs2-0126" title="MasonL , MooreRA , EdwardsJE , DerryS , McQuayHJ . Topical NSAIDs for acute pain: a meta‐analysis. BMC Family Practice2004;5:10. ">Mason 2004a</a>; <a href="./references#CD007402-bbs2-0127" title="MasonL , MooreRA , EdwardsJE , DerryS , McQuayHJ . Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta‐analysis. BMC Musculoskeletal Disorders2004;5:28. ">Mason 2004b</a>; <a href="./references#CD007402-bbs2-0130" title="MooreRA , TramèrMR , CarrollD , WiffenPJ , McQuayHJ . Quantitative systematic review of topically applied non‐steroidal anti‐inflammatory drugs. BMJ1998;316(7128):333‐8. ">Moore 1998a</a>). In the US, the Food and Drug Administration licensed topical nonsteroidal products in 2007, and in England, the National Institute for Health and Care Excellence (NICE) recommended topical therapies as first line treatment in its guidelines for osteoarthritis in 2008 (<a href="./references#CD007402-bbs2-0138" title="National Institute for Health and Care Excellence. Osteoarthritis. The care and management of osteoarthritis in adults, 2008. www.nice.org.uk/CG059fullguideline. ">NICE 2008</a>). Earlier reviews of topical analgesics covered studies investigating the underlying science to explain biological plausibility in addition to clinical trials (<a href="./references#CD007402-bbs2-0109" title="Anon . Topical analgesics: a review of reviews and a bit of perspective. www.jr2.ox.ac.uk/Bandolier/Extraforbando/Topextra3.pdf2005. ">Anon 2005</a>; <a href="./references#CD007402-bbs2-0134" title="MooreRA , DerryS , McQuayHJ . Topical agents in the treatment of rheumatic pain. Rheumatic Diseases Clinics of North America2008;34(2):415‐32. ">Moore 2008a</a>). </p> <p>This review is one of a series on topical analgesics, including topical capsaicin at low and high doses (<a href="./references#CD007402-bbs2-0113" title="DerryS , MooreRA . Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD010111] ">Derry 2012a</a>; <a href="./references#CD007402-bbs2-0115" title="DerryS , Sven‐RiceA , ColeP , TanT , MooreRA . Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD007393.pub3] ">Derry 2013</a>), and topical NSAIDs in chronic pain conditions (<a href="./references#CD007402-bbs2-0114" title="DerryS , MooreRA , RabbieR . Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD007400.pub2] ">Derry 2012b</a>), and salicylate‐containing rubefacients (<a href="./references#CD007402-bbs2-0116" title="DerryS , MatthewsPR , WiffenPJ , MooreRA . Salicylate‐containing rubefacients for acute and chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews2014, Issue 11. [DOI: 10.1002/14651858.CD007403.pub3] ">Derry 2014</a>). </p> <section id="CD007402-sec-0024"> <h3 class="title" id="CD007402-sec-0024">Description of the condition</h3> <p>Acute pain is usually defined as pain of less than three months' duration. It is often associated with injury, including trauma; surgery; musculoskeletal injuries such as strains, sprains, and over‐use injuries; or soft tissue injuries such as muscle soreness or cramps. </p> </section> <section id="CD007402-sec-0025"> <h3 class="title" id="CD007402-sec-0025">Description of the intervention</h3> <p>Clinicians prescribe NSAIDs on a routine basis for a range of mild to moderate pain. NSAIDs are the most commonly prescribed analgesic medications worldwide, and their efficacy for treating acute pain has been well demonstrated (<a href="./references#CD007402-bbs2-0132" title="MooreRA , EdwardsJ , BardenJ , McQuayHJ . Bandolier's Little Book of Pain. Oxford: Oxford University Press, 2003. [ISBN: 0‐19‐263247‐7] ">Moore 2003</a>). They reversibly inhibit cyclooxygenase (prostaglandin endoperoxide synthase), the enzyme mediating production of prostaglandins and thromboxane A2 (<a href="./references#CD007402-bbs2-0118" title="FitzGeraldGA , PatronoC . The coxibs, selective inhibitors of cyclooxygenase‐2. New England Journal of Medicine2001;345(6):433‐42. ">FitzGerald 2001</a>). Prostaglandins mediate a variety of physiological functions such as maintenance of the gastric mucosal barrier, regulation of renal blood flow, and regulation of endothelial tone. They also play an important role in inflammatory and nociceptive processes. However, relatively little is known about the mechanism of action of this class of compounds aside from their ability to inhibit cyclooxygenase‐dependent prostanoid formation (<a href="./references#CD007402-bbs2-0120" title="HawkeyCJ . Cox‐2 inhibitors. Lancet1999;353(9149):307‐14. ">Hawkey 1999</a>). </p> <p>NSAIDs taken orally or intravenously are transported to all parts of the body in the blood, and relatively high blood concentrations are needed to achieve effective tissue concentrations at the site of the pain and inflammation. These high concentrations throughout the body can give rise to a number of adverse events that can be unpleasant (for example, dyspepsia) or potentially serious (for example, gastrointestinal bleeding). </p> <p>A topical medication is a one applied to body surfaces such as the skin or mucous membranes to treat ailments. A large range of types of topical formulation may be used, including but not limited to creams, foams, gels, lotions, ointments, and plasters. The exact formulation of a topical medication is often determined by the speed of drug absorption required. The need may be for slow absorption into the circulation to maintain low drug concentrations, and, perhaps, avoiding extensive first pass metabolism in the liver; plasters containing drug reservoirs may be used for this, as with transdermal opioids or contraceptive steroids. For rapid absorption, the formulation is enhanced by substances to improve or assist skin penetration, perhaps only to generate high concentrations in tissues rather than in the blood; gel formulations are useful for this purpose, which is why they are sometimes used for topical NSAIDs. </p> <section id="CD007402-sec-0026"> <h4 class="title">Topical NSAIDs</h4> <p>Topical NSAIDs are formulated for direct application to the painful site, and to produce a local pain‐relieving effect while avoiding body‐wide distribution of the drug at physiologically active levels (<a href="./references#CD007402-bbs2-0128" title="McPhersonML , CiminoNM . Topical NSAID formulations. Pain Medicine2013;14 Suppl 1:S35‐9. [DOI: 10.1111/pme.12288] ">McPherson 2013</a>). This method of application (dosing) necessarily limits their use to more superficial painful conditions such as sprains, strains, and muscle or tendon soreness. They would not, for example, be indicated for deep visceral pain or headaches. They are also not appropriate for use on broken skin, so would not be used on open wounds (accidental or surgical). </p> </section> </section> <section id="CD007402-sec-0027"> <h3 class="title" id="CD007402-sec-0027">How the intervention might work</h3> <p>For a topical formulation to be effective, it must first penetrate the skin. Only when the drug has entered the lower layers of the skin can it be absorbed by the blood and transported to the site of action, or penetrate deeper into areas where inflammation occurs. Individual drugs have different degrees of penetration. A balance between lipid and aqueous solubility is needed to optimise penetration, and use of prodrug esters has been suggested as a way of enhancing permeability. Formulation is also crucial to good skin penetration. Experiments with artificial membranes or human epidermis suggest that creams are generally less effective than gels or sprays, but newer formulations such as microemulsions may have greater potential. </p> <p>Once the drug has reached the site of action, it must be present at a sufficiently high concentration to inhibit cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. This in turn reduces inflammation and relieves pain. It is probable that in acute conditions, topical NSAIDs exert their action primarily by local reduction of symptoms, independent of any systemic uptake and delivery. Tissue levels of NSAIDs applied topically certainly reach levels high enough to inhibit cyclooxygenase‐2 (<a href="./references#CD007402-bbs2-0109" title="Anon . Topical analgesics: a review of reviews and a bit of perspective. www.jr2.ox.ac.uk/Bandolier/Extraforbando/Topextra3.pdf2005. ">Anon 2005</a>; <a href="./references#CD007402-bbs2-0119" title="HaroutiunianS , DrennanDA , LipmanAG . Topical NSAID therapy for musculoskeletal pain. Pain Medicine2010;11(4):535‐49. [DOI: 10.1111/j.1526‐4637.2010.00809.x] ">Haroutiunian 2010</a>; <a href="./references#CD007402-bbs2-0134" title="MooreRA , DerryS , McQuayHJ . Topical agents in the treatment of rheumatic pain. Rheumatic Diseases Clinics of North America2008;34(2):415‐32. ">Moore 2008a</a>). However, plasma concentrations found after topical administration are only a fraction (usually much less than 5%) of the levels found in plasma following oral administration. Topical application can potentially limit systemic adverse events by increasing local effects, and minimising systemic concentrations of the drug. We know that the incidence of upper gastrointestinal bleeding is low with chronic use of topical NSAIDs (<a href="./references#CD007402-bbs2-0117" title="EvansJM , McMahonAD , McGilchristMM , WhiteG , MurrayFE , McDevittDG , et al. Topical non‐steroidal anti‐inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case‐control study. BMJ1995;311(6996):22‐6. ">Evans 1995</a>), although it has been reported, particularly in people with risk factors (<a href="./references#CD007402-bbs2-0147" title="ZimmermanJ , SiguenciaJ , TsvangE . Upper gastrointestinal hemorrhage associated with cutaneous application of diclofenac gel. American Journal of Gastroenterology1995;90(11):2032‐4. [PUBMED: 7485017] ">Zimmerman 1995</a>). We have no certain knowledge of lower effects on cardiovascular events, or renal failure, both of which have been associated with oral NSAID use. </p> </section> <section id="CD007402-sec-0028"> <h3 class="title" id="CD007402-sec-0028">Why it is important to do this review</h3> <p>Since the last review in 2010, a number of new studies have been published, nearly all of which investigated various formulations of diclofenac. These new studies are generally of higher quality than many of the earlier ones in this review, and have the potential to influence the strength of its conclusions substantially. Moreover, the additional information allows for analysis based not only on a particular drug, but also on the formulation of that drug. This can provide better insight into whether formulation affects efficacy of topical NSAIDs in acute musculoskeletal pain. </p> <p>An updated review of evidence for topical NSAIDs was needed to inform choices made by consumers, prescribers, and commissioners (purchasers of healthcare). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007402-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007402-sec-0029"></div> <p>To determine the efficacy and safety of topically applied NSAIDs in acute musculoskeletal pain in adults. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007402-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007402-sec-0030"></div> <section id="CD007402-sec-0031"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007402-sec-0032"> <h4 class="title">Types of studies</h4> <p>Randomised controlled double‐blind studies comparing topical NSAIDs with placebo (inert carrier) or other active treatment for acute pain, with at least 10 participants per treatment arm and outcomes close to seven days (minimum three days). We excluded studies published only as short abstracts (which report insufficient data to assess methods) or studying experimentally induced pain (which does not correlate well with clinical pain). Because a cross‐over design is not appropriate for self limiting conditions such as sprains, strains, and contusions, we only considered parallel‐group designs. </p> </section> <section id="CD007402-sec-0033"> <h4 class="title">Types of participants</h4> <p>Adults (aged 16 years or more) with acute musculoskeletal pain of at least moderate intensity resulting mainly from strains, sprains, or sports injuries. Typically for sports injuries, the injury would have occurred within 24 or 48 hours. </p> </section> <section id="CD007402-sec-0034"> <h4 class="title">Types of interventions</h4> <p>Included studies had at least one treatment arm using a topical NSAID and a comparator arm using placebo (inert carrier without NSAID or other active treatment). The topical NSAID had to be applied at least once daily. We did not include salicylates in this review as they are no longer classified as topical NSAIDs and are covered in a separate review (<a href="./references#CD007402-bbs2-0116" title="DerryS , MatthewsPR , WiffenPJ , MooreRA . Salicylate‐containing rubefacients for acute and chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews2014, Issue 11. [DOI: 10.1002/14651858.CD007403.pub3] ">Derry 2014</a>). </p> </section> <section id="CD007402-sec-0035"> <h4 class="title">Types of outcome measures</h4> <p>We sought information on participant characteristics including age, sex, and condition treated. </p> <section id="CD007402-sec-0036"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome was 'clinical success', defined as at least a 50% reduction in pain or equivalent measure, such as a 'very good' or 'excellent' global assessment of treatment, or 'none' or 'slight' pain on rest or movement, measured on a categorical scale (<a href="./references#CD007402-bbs2-0130" title="MooreRA , TramèrMR , CarrollD , WiffenPJ , McQuayHJ . Quantitative systematic review of topically applied non‐steroidal anti‐inflammatory drugs. BMJ1998;316(7128):333‐8. ">Moore 1998a</a>). We used the following hierarchy of outcomes to extract data for the primary outcome. </p> <p> <ul id="CD007402-list-0001"> <li> <p>Participant reported reduction in pain of at least 50%.</p> </li> <li> <p>Participant reported global assessment of treatment.</p> </li> <li> <p>Pain on movement.</p> </li> <li> <p>Pain at rest or spontaneous pain.</p> </li> <li> <p>Undefined 'improvement'.</p> </li> </ul> </p> <p>We used only participant reported outcomes of efficacy, and not physician or investigator reported outcomes. </p> </section> <section id="CD007402-sec-0037"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD007402-list-0002"> <li> <p>Numbers of participants with adverse events: local and systemic.</p> </li> <li> <p>Numbers of withdrawals: all cause, lack of efficacy, and adverse events.</p> </li> </ul> </p> <p>We anticipated that outcomes would be reported after different durations of treatment, and extracted data reported as close to seven days as possible, with a minimum of three days. We also extracted data for outcomes reported after longer durations of treatment. We anticipated that reporting of adverse events would vary between studies with regard to the terminology used, method of ascertainment, and categories reported (for example, occurring in at least 5% of participants or where there is a statistically significant difference between treatment groups). We took care to identify these details where relevant. </p> </section> </section> </section> <section id="CD007402-sec-0038"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD007402-sec-0039"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases without language restriction:</p> <p> <ul id="CD007402-list-0003"> <li> <p>CENTRAL (<i>The Cochrane Library</i>), Issue 4, 2009 for the original review, and the Cochrane Register of Studies Online (CRSO) to 3 February 2015 for this update; </p> </li> <li> <p>MEDLINE (via Ovid), from inception to December 2009 for the original review, and from 2008 to 3 February 2015 for this update; </p> </li> <li> <p>EMBASE (via Ovid), from inception to December 2009 for the original review, and from 2008 to 3 February 2015 for this update; </p> </li> <li> <p>Oxford Pain Relief Database for the original review (<a href="./references#CD007402-bbs2-0122" title="JadadAR , CarrollD , MooreA , McQuayH . Developing a database of published reports of randomised clinical trials in pain research. Pain1996;66(2‐3):239‐46. ">Jadad 1996a</a>). This resource is no longer being updated. </p> </li> </ul> </p> <p>See <a href="./appendices#CD007402-sec-0115">Appendix 1</a> for the CENTRAL search strategy, <a href="./appendices#CD007402-sec-0116">Appendix 2</a> for the MEDLINE search strategy, and <a href="./appendices#CD007402-sec-0117">Appendix 3</a> for the EMBASE search strategy. </p> </section> <section id="CD007402-sec-0040"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of review articles and included studies. We have previously asked manufacturers for details of unpublished studies, but did not make new requests. </p> <p>We searched two clinical trial registries (clinicaltrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>) and the World Health Organization International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>)) and asked personal contacts about ongoing and unpublished studies. </p> </section> </section> <section id="CD007402-sec-0041"> <h3 class="title" id="CD007402-sec-0041">Data collection and analysis</h3> <section id="CD007402-sec-0042"> <h4 class="title">Selection of studies</h4> <p>We screened the titles and abstracts of studies identified by the searches to eliminate those that clearly did not satisfy the inclusion criteria, and obtained full reports of the remaining studies to determine inclusion in the review. </p> </section> <section id="CD007402-sec-0043"> <h4 class="title">Data extraction and management</h4> <p>Review authors were not blinded to the authors' names and institutions, journal of publication, or study results at any stage of the review. Two review authors independently selected the studies for inclusion, assessed methodological quality and risk of bias, and extracted data. We resolved disagreements and uncertainties through discussion. </p> <p>We abstracted information on participants, interventions, and outcomes from the original reports into a standard data extraction form. One review author entered data suitable for meta‐analysis into Review Manager 5 (<a href="./references#CD007402-bbs2-0142" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), and another review author checked it. </p> </section> <section id="CD007402-sec-0044"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used the Oxford Quality Score as the basis for inclusion, limiting inclusion to studies that were randomised and double‐blind as a minimum (<a href="./references#CD007402-bbs2-0123" title="JadadAR , MooreRA , CarrollD , JenkinsonC , ReynoldsDJ , GavaghanDJ , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials1996;17(1):1‐12. ">Jadad 1996b</a>). </p> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> with any disagreements resolved by discussion (<a href="./references#CD007402-bbs2-0121" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We assessed the following for each study. </p> <p> <ul id="CD007402-list-0004"> <li> <p>Random sequence generation (checking for possible selection bias). We assessed the method used to generate the allocation sequence as: low risk of bias (any truly random process, for example, random number table; computer random number generator); unclear risk of bias (method used to generate sequence was not clearly stated). We excluded studies using a non‐random process that were therefore at high risk of bias (for example, odd or even date of birth; hospital or clinic record number). </p> </li> <li> <p>Allocation concealment (checking for possible selection bias). The method used to conceal allocation to interventions before assignment determines whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. We assessed the methods as: low risk of bias (for example, telephone or central randomisation; consecutively numbered sealed opaque envelopes); unclear risk of bias (method was not clearly stated). We excluded studies that did not conceal allocation and were therefore at high risk of bias (for example, open list). </p> </li> <li> <p>Blinding of outcome assessment (checking for possible detection bias). We assessed the methods used to blind study participants and outcome assessors from knowledge of which intervention a participant received. We assessed the methods as: low risk of bias (study stated that it was blinded and described the method used to achieve blinding, for example, identical tubes containing gel, or identical plasters; matched in appearance and smell); unclear risk of bias (study stated that it was blinded but did not provide an adequate description of how blinding was achieved). We excluded studies that were not double‐blind and were therefore at high risk of bias. </p> </li> <li> <p>Incomplete outcome data (checking for possible attrition bias due to the amount, nature, and handling of incomplete outcome data). We assessed the methods used to deal with incomplete data as: low risk of bias (less than 10% of participants did not complete the study or used 'baseline observation carried forward' analysis, or both); unclear risk of bias (used 'last observation carried forward' analysis); or high risk of bias (used 'completer' analysis). </p> </li> <li> <p>Size (checking for possible biases confounded by small size). Small studies have been shown to overestimate treatment effects, probably due to methodological weaknesses (<a href="./references#CD007402-bbs2-0112" title="DechartresA , TrinquartL , BoutronI , RavaudP . Influence of trial sample size on treatment effect estimates: meta‐epidemiological study. BMJ2013;346:f2304. [DOI: 10.1136/bmj.f2304] ">Dechartres 2013</a>; <a href="./references#CD007402-bbs2-0139" title="NüeschE , TrelleS , ReichenbachS , RutjesAW , TschannenB , AltmanDG , et al. Small study effects in meta‐analyses of osteoarthritis trials: meta‐epidemiological study. BMJ2010;341:c3515. [DOI: 10.1136/bmj.c3515] ">Nüesch 2010</a>). We assessed studies as at low risk of bias if they had at least 200 participants, at unclear risk if they had 50 to 200 participants, and at high risk if they had fewer than 50 participants. </p> </li> </ul> </p> </section> <section id="CD007402-sec-0045"> <h4 class="title">Measures of treatment effect</h4> <p>We used risk ratio (RR) to establish statistical difference and numbers needed to treat for an additional beneficial outcome (NNT) with 95% confidence intervals (CI). We pooled percentages as absolute measures of benefit or harm. </p> <p>We used the following terms to describe adverse outcomes in terms of harm or prevention of harm. </p> <p> <ul id="CD007402-list-0005"> <li> <p>When significantly fewer adverse outcomes occurred with treatment than with control (placebo or active), we used the term the<i>number needed to treat to prevent one event</i> (NNTp). </p> </li> <li> <p>When significantly more adverse outcomes occurred with treatment compared with control (placebo or active), we used the term the <i>number needed to treat for an additional harmful outcome or cause one event</i> (NNH). </p> </li> </ul> </p> </section> <section id="CD007402-sec-0046"> <h4 class="title">Unit of analysis issues</h4> <p>Randomisation was to the individual participant.</p> </section> <section id="CD007402-sec-0047"> <h4 class="title">Dealing with missing data</h4> <p>Wherever possible we used intention‐to‐treat (ITT) analysis where the ITT population consists of participants who were randomised, applied at least one dose of the assigned study medication, and provided at least one post‐baseline assessment. We assigned missing participants zero improvement. </p> <p>We also looked for information about methods of imputation for missing data.</p> </section> <section id="CD007402-sec-0048"> <h4 class="title">Assessment of heterogeneity</h4> <p>We examined heterogeneity visually using L'Abbé plots (<a href="./references#CD007402-bbs2-0124" title="L'AbbéKA , DetskyAS , O'RourkeK . Meta‐analysis in clinical research. Annals of Internal Medicine1987;107(2):224‐33. ">L'Abbé 1987</a>), a visual method for assessing differences in results of individual studies, and with the I<sup>2</sup> statistic. </p> </section> <section id="CD007402-sec-0049"> <h4 class="title">Assessment of reporting biases</h4> <p>The aim of this review was to use dichotomous outcomes of known utility and of value to patients (<a href="./references#CD007402-bbs2-0136" title="MooreRA , StraubeS , AldingtonD . Pain measures and cut‐offs ‐ 'no worse than mild pain' as a simple, universal outcome. Anaesthesia2013;68(4):400‐12. [DOI: 10.1111/anae.12148] ">Moore 2013</a>). The review did not depend on what the authors of the original studies chose to report or not. Studies that did not report dichotomous results, but only average pain data, did not contribute to analyses. </p> <p>We assessed publication bias using a method designed to detect the amount of unpublished data with a null effect required to make any result clinically irrelevant (usually taken to mean an NNT of 10 or higher; <a href="./references#CD007402-bbs2-0135" title="MooreRA , BardenJ , DerryS , McQuayHJ . Managing potential publication bias. In: McQuayHJ , KalsoE , MooreRA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15‐24. [ISBN: 978‐0‐931092‐69‐5] ">Moore 2008b</a>). </p> </section> <section id="CD007402-sec-0050"> <h4 class="title">Data synthesis</h4> <p>We pooled data only for comparisons and outcomes where there were at least two studies and 200 participants (<a href="./references#CD007402-bbs2-0131" title="MooreRA , GavaghanD , TramèrMR , CollinsSL , McQuayHJ . Size is everything ‐ large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain1998;78(3):209‐16. ">Moore 1998b</a>). When two active treatment arms were compared with a placebo arm, we took care to avoid double counting of participants in the placebo arm: if both active groups contributed to an analysis, we split the placebo group between them. </p> <p>We calculated RRs with 95% CIs using the fixed‐effect model (<a href="./references#CD007402-bbs2-0137" title="MorrisJA , GardnerMJ . Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates. In: GardnerMJ , AltmanDG editor(s). Statistics with Confidence ‐ Confidence Intervals and Statistical Guidelines. London: British Medical Journal, 1995:50‐63. ">Morris 1995</a>). A statistically significant benefit of topical NSAID over control was assumed when the lower limit of the 95% CI of the RR was greater than one. A statistically significant benefit of control over active treatment was assumed when the upper limit of the 95% CI was less than one. We calculated NNTs with 95% CIs using the pooled number of events by the method of Cook and Sackett (<a href="./references#CD007402-bbs2-0110" title="CookRJ , SackettDL . The number needed to treat: a clinically useful measure of treatment effect. BMJ1995;310(6977):452‐4. ">Cook 1995</a>). </p> <p>Statistically significant differences between NNTs for different topical NSAIDs were tested using the z test (<a href="./references#CD007402-bbs2-0145" title="TramerMR , ReynoldsDJ , MooreRA , McQuayHJ . Impact of covert duplicate publication on meta‐analysis: a case study. BMJ1997;315(7109):635‐40. ">Tramer 1997</a>), where there were sufficient data to do so, and where the studies were sufficiently similar in types of participant, outcome, and duration to make such comparisons sensible. </p> </section> <section id="CD007402-sec-0051"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We carried out separate analyses for individual NSAIDs, and, where the data permitted, for different formulations of individual NSAIDs. </p> </section> <section id="CD007402-sec-0052"> <h4 class="title">Sensitivity analysis</h4> <p>The earlier review included sensitivity analyses for various factors that are now covered by the assessment of risk of bias. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007402-sec-0053" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007402-sec-0053"></div> <section id="CD007402-sec-0054"> <h3 class="title">Description of studies</h3> <section id="CD007402-sec-0055"> <h4 class="title">Results of the search</h4> <p>New searches for this update identified 20 publications that were examined in further detail to determine inclusion status. We also identified 20 additional studies in clinical trial registries. See <a href="#CD007402-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD007402-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD007402-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>We identified 14 new studies (11 publications, three unpublished reports) satisfying our inclusion criteria (<a href="./references#CD007402-bbs2-0008" title="CostantinoC , KwareckiJ , SamokhinAV , MautoneG , RovatiS . Diclofenac epolamine plus heparin plaster versus diclofenac epolamine plaster in mild to moderate ankle sprain: a randomized, double‐blind, parallel‐group, placebo‐controlled, multicentre, phase III trial. Clinical Drug Investigation2011;31(1):15‐26. [DOI: 10.2165/11585890‐000000000‐00000] ">Costantino 2011</a>; <a href="./references#CD007402-bbs2-0009" title="CoudreuseJM , deVathaireF . Effect of a plaster containing DHEP and heparin in acute ankle sprains with oedema: a randomized, double‐blind, placebo‐controlled, clinical study. Current Medical Research and Opinion2010;26(9):2221‐8. [DOI: 10.1185/03007995.2010.508020] ">Coudreuse 2010</a>; <a href="./references#CD007402-bbs2-0019" title="González de VegaC , SpeedC , WolfarthB , GonzálezJ . Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: a multicentre, randomised, blinded, controlled and non‐inferiority trial. International Journal of Clinical Practice2013;67(10):979‐89. [DOI: 10.1111/ijcp.12219] ">González de Vega 2013</a>; <a href="./references#CD007402-bbs2-0024" title="HofmanJ , NasswetterG , CayettiLM . Lysine clonixinate gel in soft tissue injuries. Controlled randomized prospective double‐blind clinical trial with diclofenac [Clonixinato de lisina gel en lesiones de tejidos blandos ensayo clinico prospectivo doble ciego al azar controlado con diclofenac]. Prensa Medica Argentina2000;87(5):513‐20. ">Hofman 2000</a>; <a href="./references#CD007402-bbs2-0029" title="KlaingutiA , ForgacsA , BerkesI , CastellacciE . A plaster containing DHEP and heparin for mild to moderate contusions and sprains with haematoma: a double‐blind randomized study. Current Medical Research and Opinion2010;26(9):2243‐51. [DOI: 10.1185/03007995.2010.508022] ">Klainguti 2010</a>; <a href="./references#CD007402-bbs2-0031" title="KuehlK , CarrW , YanchickJ , MagelliM , RovatiS . Analgesic efficacy and safety of the diclofenac epolamine topical patch 1.3% (DETP) in minor soft tissue injury. International Journal of Sports Medicine2011;32(8):635‐43. [DOI: 10.1055/s‐0031‐1275359] ">Kuehl 2011</a>; <a href="./references#CD007402-bbs2-0032" title="LiC , FrangioneV , RovatiS , ZhengQ . Diclofenac epolamine medicated plaster in the treatment of minor soft tissue injuries: a multicenter randomized controlled trial. Current Medical Research and Opinion2013;29(9):1137‐46. [DOI: 10.1185/03007995.2013.816669] ">Li 2013</a>; <a href="./references#CD007402-bbs2-0040" title="Novartis(Sponsors) . A randomized, double‐blind, multi‐center, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied 4 times daily in subjects with acute ankle sprain. clinicaltrials.gov/ct2/show/NCT01255423 (accessed 3 February 2015)2012. [CTG: NCT01255423] ">NCT01255423</a>; <a href="./references#CD007402-bbs2-0041" title="Novartis(Sponsors) . A randomized, double‐blind, multi‐center, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied four times daily in subjects with acute ankle sprain. clinicaltrials.gov/ct2/show/results/NCT01272934 (accessed 3 February 2015)2013. [CTG: NCT01272934] ">NCT01272934</a>; <a href="./references#CD007402-bbs2-0042" title="Novartis(Sponsors) . A randomized, double‐blind, multi‐center, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied four times daily in subjects with acute blunt soft tissue injuries/contusions of the limbs. clinicaltrials.gov/ct2/show/results/NCT01272947 (accessed 3 February 2015)2012. [CTG: NCT01272947] PallayR , PabstH , GiannettiB , BurnettI , MonnetJ . Diclofenac sodium topical gel (DSG) 1% for acute soft tissue injuries/contusions of the limbs. 2013 Annual Assembly of the American Academy of Physical Medicine and Rehabilitation. National Harbor, MD United States, 2013; Vol. 5 (9 Suppl 1):S204. ">NCT01272947</a>; <a href="./references#CD007402-bbs2-0047" title="PredelHG , HamelskyS , GoldM , GiannettiB . Efficacy and safety of diclofenac diethylamine 2.32% gel in acute ankle sprain. Medicine and Science in Sports and Exercise2012;44(9):1629‐36. [DOI: 10.1249/MSS.0b013e318257ed41] ">Predel 2012</a>; <a href="./references#CD007402-bbs2-0048" title="PredelHG , GiannettiB , SeigfriedB , NovelliniR , MenkeG . A randomized, double‐blind, placebo‐controlled multicentre study to evaluate the efficacy and safety of diclofenac 4% spray gel in the treatment of acute uncomplicated ankle sprain. Journal of International Medical Research2013;41(4):1187‐202. [DOI: 10.1177/0300060513487639] ">Predel 2013a</a>; <a href="./references#CD007402-bbs2-0049" title="PredelHG , GiannettiB , PabstH , SchaeferA , HugAM , BurnettI . Efficacy and safety of diclofenac diethylamine 1.16% gel in acute neck pain: a randomized, double‐blind, placebo‐controlled study. BMC Musculoskeletal Disorders2013;14:250. [DOI: 10.1186/1471‐2474‐14‐250] ">Predel 2013b</a>; <a href="./references#CD007402-bbs2-0053" title="LionbergerDR , JoussellinE , YanchickJ , MagelliM , LanzarottiA . Pooled analysis of clinical trial data evaluating the safety and effectiveness of diclofenac epolamine topical patch 1.3% for the treatment of acute ankle sprain. Open Access Journal of Sports Medicine2011;2:75‐84. [DOI: 10.2147/OAJSM.S17048] SaillantG . Study comparing the efficacy and tolerance of Flector Tissugel® to that of a placebo in the treatment of benign ankle sprains [Étude comparant l’efficacité et la tolérance de FlectorTissugel® à celles d’un placebo dans le traitement des entorses bénignes de la cheville]. Medicine du Sport1998;72:1‐5. ">Saillant 1998</a>), one post hoc analysis of a study that was included in the earlier review (Mueller 2010 in <a href="./references#CD007402-bbs2-0046" title="MuellerEA , KirchW , ReiterS . Extent and time course of pain intensity upon treatment with a topical diclofenac sodium patch versus placebo in acute traumatic injury based on a validated end point: post hoc analysis of a randomized placebo‐controlled trial. Expert Opinion on Pharmacotherapy2010;11(4):493‐8. [DOI: 10.1517/14656560903535898] PredelHG , KollR , PabstH , DieterR , GallacchiG , GiannettiB , et al. Diclofenac patch for topical treatment of acute impact injuries: a randomised, double blind, placebo controlled, multicentre study. British Journal of Sports Medicine2004;38(3):318‐23. [DOI: 10.1136/bjsm.2003.005017] ">Predel 2004</a>), and an additional publication and a pooled analysis that included new data for another study from the earlier review (Lionberger 2011 pooled analysis in <a href="./references#CD007402-bbs2-0027" title="JoussellinE . Flector Tissugel for the treatment of painful ankle sprains [Flector Tissugel dans le traitement des entorses douloureuses de la cheville]. Journal de Traumatologie du Sport2003;20:1S5‐9. LionbergerDR , JoussellinE , LanzarottiA , YanchickJ , MagelliM . Diclofenac epolamine topical patch relieves pain associated with ankle sprain. Journal of Pain Research2011;4:47‐53. [DOI: 10.2147/JPR.S15380] LionbergerDR , JoussellinE , YanchickJ , MagelliM , LanzarottiA . Pooled analysis of clinical trial data evaluating the safety and effectiveness of diclofenac epolamine topical patch 1.3% for the treatment of acute ankle sprain. Open Access Journal of Sports Medicine2011;2:75‐84. [DOI: 10.2147/OAJSM.S17048] ">Joussellin 2003</a>). </p> </section> <section id="CD007402-sec-0056"> <h4 class="title">Included studies</h4> <p>All except one of the new studies compared diclofenac with placebo. A number of different formulations were used, including diclofenac epolamine (DHEP) with or without heparin (Flectoparin Tissugel or Flector EP Tissugel) applied as a plaster (or patch), diclofenac diethylamine (DDEA) applied as a gel, and diclofenac with lethicin applied as a spray gel. The remaining study compared diclofenac gel with traumeel, a "fixed combination of plant and mineral extracts", applied as a gel or an ointment. </p> <p>There were 47 studies in the original review; 14 new studies were included making a total of 61 studies in this updated review. All used a parallel group design. Forty‐four compared a topical NSAID with placebo, 13 a topical NSAID with an active comparator (a different topical NSAID, an oral NSAID, the same topical NSAID in a different formulation, or a compound of plant and mineral extracts), and four had both placebo and active comparators. In total, 5311 participants were treated with a topical NSAID, 3470 with placebo, and 220 with an oral NSAID. Topical NSAIDs used were benzydamine, diclofenac, etofenamate, felbinac, fentiazac, flunoxaprophen, flurbiprofen, ibuprofen, indomethacin, ketoprofen, ketorolac, lysine clonixinate, meclofenamic acid, naproxen, niflumic acid, and piroxicam. They were applied as creams, gels, sprays, foams, or plasters (patches). Topical placebos were the inert carriers, without the active NSAID. Oral NSAIDs used were ibuprofen (as tablets) and indomethacin (as capsules). </p> <p>Most studies enrolled participants who had sprains, strains, and contusions, usually as a result of sports injuries, and treatment was started within a few hours or days. Other studies enrolled participants with overuse‐type injuries, such as tendinitis and acute low back pain, where pain had been present for days or weeks, but less than three months. </p> <p>Participants were treated for at least five days, and up to three weeks, with most studies lasting seven to 14 days. Participants were usually assessed in clinic at intervals during treatment, and sometimes also at home using daily patient diaries. We used outcomes closest to seven days because many of these injuries are self limiting, with differences between active treatment and placebo being diminished or lost after longer intervals. </p> <p>Most studies reported dichotomous outcomes suitable for a responder analysis, although group mean change (for pain or physical function, for example) was usually the primary outcomes. However, the definition of response varied both in the parameter measured (for example, pain, pain on movement, patient global evaluation of treatment), and in the scale used to measure it (for example, a 3‐, 4‐, or 5‐point scale for patient global evaluation). </p> <p>Details of included studies are in the <a href="./references#CD007402-sec-0147" title="">Characteristics of included studies</a> table. </p> <p>We identified 14 completed but apparently unpublished studies in a clinical trial registry for which no results have been posted (4403 participants, <a href="./references#CD007402-bbs2-0091" title="Endo Pharmaceuticals(Sponsors) . A randomized, double‐blind, placebo‐controlled, parallel group phase III study of the efficacy, tolerability and safety of ketoprofen topical patch, 20% (KTP) in the treatment of pain associated with grade 1 or grade 2 ankle sprain or strain. clinicaltrials.gov/ct2/show/NCT00351104 (accessed 3 February 2015)2008. [CTG: NCT00351104] ">NCT00351104</a>; <a href="./references#CD007402-bbs2-0092" title="Endo Pharmaceuticals(Sponsors) . A randomized, double‐blind, placebo‐controlled, parallel group phase III study of the efficacy, tolerability and safety of ketoprofen topical patch, 20% (KTP) in the treatment of pain associated with tendonitis or bursitis of the shoulder, elbow or knee. clinicaltrials.gov/ct2/show/NCT00352625 (accessed 3 February 2015)2008. [CTG: NCT00352625] ">NCT00352625</a>; <a href="./references#CD007402-bbs2-0093" title="Endo Pharmaceuticals(Sponsors) . A randomized, double‐blind, placebo‐controlled, parallel group phase iii study of the efficacy, tolerability and safety of ketoprofen topical patch, 20% (KTP) in the treatment of pain associated with tendonitis or bursitis of the shoulder, elbow or knee. clinicaltrials.gov/ct2/show/NCT00426985 (accessed 3 February 2015)2008. [CTG: NCT00426985] ">NCT00426985</a>; <a href="./references#CD007402-bbs2-0094" title="Cerimon Pharmaceuticals(Sponsors) . A randomized, double‐blind, placebo‐controlled study of the efficacy and safety of a diclofenac sodium patch for the topical treatment of pain due to mild to moderate ankle sprain. clinicaltrials.gov/ct2/show/NCT00640705 (accessed 3 February 2015)2008. [CTG: NCT00640705] ">NCT00640705</a>; <a href="./references#CD007402-bbs2-0095" title="Cerimon Pharmaceuticals(Sponsors) . A randomized, double‐blind, placebo‐controlled study of the efficacy and safety of a diclofenac sodium patch for the topical treatment of pain due to mild to moderate tendonitis or bursitis. clinicaltrials.gov/ct2/show/NCT00640939 (accessed 3 February 2015)2008. [CTG: NCT00640939] ">NCT00640939</a>; <a href="./references#CD007402-bbs2-0096" title="Hisamitsu PharmaceuticalCo , Inc (Sponsors). A randomized, multicenter, double‐blind, placebo‐controlled, two‐week study to assess the efficacy and safety of HKT‐500 in subjects with acute shoulder pain. clinicaltrials.gov/ct2/show/NCT00680472 (accessed 3 February 2015)2015. [CTG: NCT00680472] ">NCT00680472</a>; <a href="./references#CD007402-bbs2-0097" title="Hisamitsu PharmaceuticalCo , Inc (Sponsors). A randomized, multicenter, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of HKT‐500 in the treatment of pain associated with Grade I or Grade II ankle sprain. clinicaltrials.gov/ct2/show/NCT00680784 (accessed 3 February 2015)2015. [CTG: NCT00680784] ">NCT00680784</a>; <a href="./references#CD007402-bbs2-0098" title="EkmanE , SkrepnikS , JonesM , LawsonK , SchuppJ . Efficacy and safety of ketoprofen 10% cream in acute soft tissue injuries (phase 3 study tdlp‐110‐001). Proceedings of the 13th World Congress on Pain 2010 Aug 29 – Sept 2; Montreal, Canada. ImprimisPharmaceuticals , Inc (Sponsors). A randomized, multicenter, double‐blind, placebo‐controlled, parallel‐group, phase 3 study to assess the efficacy and safety of Ketotransdel™ (Ketoprofen topical cream 10%) in the treatment of pain associated with mild to moderate acute soft tissue injury. clinicaltrials.gov/ct2/show/NCT00765700 (accessed 3 February 2015)2013. [CTG: NCT00765700] ">NCT00765700</a>; <a href="./references#CD007402-bbs2-0099" title="Cerimon Pharmaceuticals(Sponsors) . A randomized, double‐blind, placebo‐controlled study of the efficacy and safety of a diclofenac sodium patch for the topical treatment of acute pain due to mild to moderate wrist sprain, strain or contusion. clinicaltrials.gov/ct2/show/NCT00869063 (accessed 3 February 2015)2010. [CTG: NCT00869063] ">NCT00869063</a>; <a href="./references#CD007402-bbs2-0100" title="Cerimon Pharmaceuticals(Sponsors) . A randomized, double‐blind, placebo‐controlled study of the efficacy and safety of a diclofenac sodium patch for the topical treatment of acute pain due to mild to moderate ankle sprain. clinicaltrials.gov/ct2/show/NCT00869180 (accessed 3 February 2015)2010. [CTG: NCT00869180] ">NCT00869180</a>; <a href="./references#CD007402-bbs2-0101" title="Cerimon Pharmaceuticals(Sponsors) . A randomized, double‐blind, placebo‐controlled study of the efficacy and safety of a diclofenac sodium patch for the topical treatment of acute pain due to mild to moderate soft tissue injuries. clinicaltrials.gov/ct2/show/NCT00931866 (accessed 3 February 2015)2010. [CTG: NCT00931866] ">NCT00931866</a>; <a href="./references#CD007402-bbs2-0102" title="Strategic Science &amp; Technologies, LLC(Sponsors) . A randomized, double‐blind, placebo‐controlled, multi‐dose, pivotal study to determine the efficacy and safety of SST 0225, a topical ibuprofen cream, in the treatment of pain associated with acute ankle sprain. clinicaltrials.gov/ct2/show/NCT01874626 (accessed 3 February 2015)2014. [CTG: NCT01874626] ">NCT01874626</a>; <a href="./references#CD007402-bbs2-0103" title="GlaxoSmithKline(Sponsors) . A clinical study to assess the efficacy of pain relief of topical indomethacin patch over placebo in ankle sprain patients. clinicaltrials.gov/ct2/show/NCT01957215 (accessed 3 February 2015)2015. [CTG: NCT01957215] ">NCT01957215</a>; <a href="./references#CD007402-bbs2-0104" title="Actavis Inc (Sponsors). Randomized, double‐blind, multiple‐center, placebo‐controlled study comparing the safety and efficacy of generic diclofenac epolamine to Flector® patch in the treatment of acute pain due to minor ankle sprain. clinicaltrials.gov/ct2/show/NCT02324270 (accessed 3 February 2015)2014. [CTG: NCT02324270] ">NCT02324270</a>). We have placed these under <a href="./references#CD007402-sec-0149" title="">Characteristics of studies awaiting classification</a>. We also identified three conference abstracts that relate to completed studies that do not appear to have been published, but that may satisfy our inclusion criteria. One is likely to be the same study as one of the included studies identified in a clinical trial registry (Pallay 2013 in <a href="./references#CD007402-bbs2-0042" title="Novartis(Sponsors) . A randomized, double‐blind, multi‐center, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied four times daily in subjects with acute blunt soft tissue injuries/contusions of the limbs. clinicaltrials.gov/ct2/show/results/NCT01272947 (accessed 3 February 2015)2012. [CTG: NCT01272947] PallayR , PabstH , GiannettiB , BurnettI , MonnetJ . Diclofenac sodium topical gel (DSG) 1% for acute soft tissue injuries/contusions of the limbs. 2013 Annual Assembly of the American Academy of Physical Medicine and Rehabilitation. National Harbor, MD United States, 2013; Vol. 5 (9 Suppl 1):S204. ">NCT01272947</a>), one relates to another study identified in the clinical trial registry that is awaiting classification (Ekman 2010 in <a href="./references#CD007402-bbs2-0098" title="EkmanE , SkrepnikS , JonesM , LawsonK , SchuppJ . Efficacy and safety of ketoprofen 10% cream in acute soft tissue injuries (phase 3 study tdlp‐110‐001). Proceedings of the 13th World Congress on Pain 2010 Aug 29 – Sept 2; Montreal, Canada. ImprimisPharmaceuticals , Inc (Sponsors). A randomized, multicenter, double‐blind, placebo‐controlled, parallel‐group, phase 3 study to assess the efficacy and safety of Ketotransdel™ (Ketoprofen topical cream 10%) in the treatment of pain associated with mild to moderate acute soft tissue injury. clinicaltrials.gov/ct2/show/NCT00765700 (accessed 3 February 2015)2013. [CTG: NCT00765700] ">NCT00765700</a>), while we could find no published or unpublished reports of the other <a href="./references#CD007402-bbs2-0105" title="Sarzi‐PuttiniP , AtzeniF , DamianiC , CasaleR , BarbagalloM , CazzolaM . A double‐blind, randomised, parallel group, active controlled, multicentre study to assess the therapeutic non‐inferiority of SKP‐021, a 0.3% ketoprofen patch, versus diclofenac sodium patch in patients with acute inflammatory musculoskeletal injuries. Proceeding of the Annual European Congress of Rheumatology of the European League Against Rheumatism, EULAR 2014 June 11‐14; Paris, France. 2014:73. ">Sarzi‐Puttini 2014</a>). </p> <p>We also identified three ongoing studies with an estimated enrolment of 880 participants (<a href="./references#CD007402-bbs2-0106" title="Pfizer(Sponsors) . Placebo‐controlled, double‐blind evaluation of the efficacy and safety of ibuprofen 5% topical gel for the treatment of ankle sprain. clinicaltrials.gov/ct2/show/NCT01945034 (accessed 3 February 2015)2014. [CTG: NCT01945034] ">NCT01945034</a>; <a href="./references#CD007402-bbs2-0107" title="GlaxoSmithKline(Sponsors) . A clinical study to assess the efficacy and onset of pain relief of topical MFC51123 diclofenac‐menthol gel versus controls in ankle sprain. clinicaltrials.gov/ct2/show/NCT02100670 (accessed 3 February 2015)2014. [ClinicalTirals.gov: NCT02100670] ">NCT02100670</a>; <a href="./references#CD007402-bbs2-0108" title="Novartis(Sponsors) . A randomized, double‐blind, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied four times daily in subjects with acute blunt soft tissue injuries/contusions of the limbs. clinicaltrials.gov/ct2/show/NCT02290821 (accessed 3 February 2015)2015. [CTG: NCT02290821] ">NCT02290821</a>). Details are in the <a href="./references#CD007402-sec-0150" title="">Characteristics of ongoing studies</a> table. </p> </section> <section id="CD007402-sec-0057"> <h4 class="title">Excluded studies</h4> <p>For the original review, 25 studies were excluded after reading the full paper. For this update, we excluded four new studies (<a href="./references#CD007402-bbs2-0069" title="CesaroneMR , BelcaroG , PellegriniL , LeddaA , VinciguerraG , RicciA , et al. Treatment of ankle sprain in patients with vascular diseases of the lower limbs. Minerva Cardioangiologica2008;56 (5 Suppl):39‐46. ">Cesarone 2008</a>; <a href="./references#CD007402-bbs2-0070" title="CoulibalySK , CourauS , StaigerC . The sprained ankle: comparative study of a comfreyroot extract ointment versus a diclofenac gel [Entorses de la cheville: étude comparative entre un extrait à base de racines de consoude et le diclofénac]. Phytothérpie2009;7:147‐9. [DOI: 10.1007/s10298‐009‐0383‐x] ">Coulibaly 2009</a>; <a href="./references#CD007402-bbs2-0080" title="KuwabaraY , HamamotoH , HikakeS , MiwaY . A randomized, multi‐center, double‐blind, placebo‐controlled phase II/III trial to evaluate the eftopical patch in the treatment of pain. Journal of Pain. 2013; Vol. 14 (4 Suppl 1):S73. ">Kuwabara 2013</a>; <a href="./references#CD007402-bbs2-0089" title="VinciguerraG , BelcaroG , CesaroneMR , ErrichiBM , DiRenzoA , ErrichiS , et al. Management of uncomplicated ankle sprains with topical or oral ketoprofen treatment. A registry study. Minerva Cardioangiologica2008;56 (5 Suppl):47‐53. ">Vinciguerra 2008</a>). Details are in the <a href="./references#CD007402-sec-0148" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD007402-sec-0058"> <h3 class="title">Risk of bias in included studies</h3> <p>All studies were randomised and double‐blind. One study scored 2/5 (<a href="./references#CD007402-bbs2-0055" title="SinnigerM , BlanchardP . Controlled clinical trial with Fentiazac cream in sport microtraumatology. Journal of International Medical Research1981;9(4):300‐2. ">Sinniger 1981</a>), 23 scored 3/5, 23 scored 4/5, and 14 scored 5/5 for methodological quality using the Oxford Quality Scale. A breakdown of the scores for individual studies is reported in the <a href="./references#CD007402-sec-0147" title="">Characteristics of included studies</a> table. </p> <p>Comments on potential biases in individual studies are reported in the 'Risk of bias' section of the <a href="./references#CD007402-sec-0147" title="">Characteristics of included studies</a> table. The findings are displayed in <a href="#CD007402-fig-0002">Figure 2</a> and <a href="#CD007402-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD007402-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007402-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD007402-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD007402-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD007402-sec-0059"> <h4 class="title">Allocation</h4> <p>All the studies were randomised but only 17 adequately described the method used to generate the random sequence. Thirteen studies adequately described the method used to conceal allocation of the sequence. No studies were at high risk of bias for this item. </p> </section> <section id="CD007402-sec-0060"> <h4 class="title">Blinding</h4> <p>All studies were double‐blind and 38 adequately described the method used to maintain the blinding. No studies were at high risk of bias for this item. </p> </section> <section id="CD007402-sec-0061"> <h4 class="title">Incomplete outcome data</h4> <p>Thirty‐six studies included all participants in the primary analysis or provided sufficient data to allow missing participants to be included as non‐responders, and were judged at low risk of bias. We judged four studies to be at high risk of attrition bias (<a href="./references#CD007402-bbs2-0006" title="CampbellJ , DunnT . Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains. Journal of Accident and Emergency Medicine1994;11(3):178‐82. ">Campbell 1994</a>; <a href="./references#CD007402-bbs2-0031" title="KuehlK , CarrW , YanchickJ , MagelliM , RovatiS . Analgesic efficacy and safety of the diclofenac epolamine topical patch 1.3% (DETP) in minor soft tissue injury. International Journal of Sports Medicine2011;32(8):635‐43. [DOI: 10.1055/s‐0031‐1275359] ">Kuehl 2011</a>; <a href="./references#CD007402-bbs2-0036" title="MazièresB , RouanetS , VelicyJ , ScarsiC , ReinerV . Topical ketoprofen patch (100 mg) for the treatment of ankle sprain: a randomized, double‐blind, placebo‐controlled study. American Journal of Sports Medicine2005;33(4):515‐23. [DOI: 10.1177/0363546504268135] ">Mazières 2005a</a>; <a href="./references#CD007402-bbs2-0052" title="RussellAL . Piroxicam 0.5% topical gel compared to placebo in the treatment of acute soft tissue injuries: a double‐blind study comparing efficacy and safety. Clinical and Investigative Medicine1991;14(1):35‐43. ">Russell 1991</a>). Three unpublished studies contributed only to adverse event analyses and accounted for all participants for these outcomes (<a href="./references#CD007402-bbs2-0040" title="Novartis(Sponsors) . A randomized, double‐blind, multi‐center, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied 4 times daily in subjects with acute ankle sprain. clinicaltrials.gov/ct2/show/NCT01255423 (accessed 3 February 2015)2012. [CTG: NCT01255423] ">NCT01255423</a>; <a href="./references#CD007402-bbs2-0041" title="Novartis(Sponsors) . A randomized, double‐blind, multi‐center, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied four times daily in subjects with acute ankle sprain. clinicaltrials.gov/ct2/show/results/NCT01272934 (accessed 3 February 2015)2013. [CTG: NCT01272934] ">NCT01272934</a>; <a href="./references#CD007402-bbs2-0042" title="Novartis(Sponsors) . A randomized, double‐blind, multi‐center, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied four times daily in subjects with acute blunt soft tissue injuries/contusions of the limbs. clinicaltrials.gov/ct2/show/results/NCT01272947 (accessed 3 February 2015)2012. [CTG: NCT01272947] PallayR , PabstH , GiannettiB , BurnettI , MonnetJ . Diclofenac sodium topical gel (DSG) 1% for acute soft tissue injuries/contusions of the limbs. 2013 Annual Assembly of the American Academy of Physical Medicine and Rehabilitation. National Harbor, MD United States, 2013; Vol. 5 (9 Suppl 1):S204. ">NCT01272947</a>). </p> </section> <section id="CD007402-sec-0062"> <h4 class="title">Other potential sources of bias</h4> <p>We judged one study that included more than 200 participants in each treatment arm to be at low risk of bias from size, but this study had a very high attrition rate (see 'Incomplete outcome data (attrition bias)') and did not report all the efficacy outcomes measured (<a href="./references#CD007402-bbs2-0031" title="KuehlK , CarrW , YanchickJ , MagelliM , RovatiS . Analgesic efficacy and safety of the diclofenac epolamine topical patch 1.3% (DETP) in minor soft tissue injury. International Journal of Sports Medicine2011;32(8):635‐43. [DOI: 10.1055/s‐0031‐1275359] ">Kuehl 2011</a>). We judged 27 studies to be at high risk because they included fewer than 50 participants per treatment arm. </p> </section> </section> <section id="CD007402-sec-0063"> <h3 class="title" id="CD007402-sec-0063">Effects of interventions</h3> <p>See: <a href="./full#CD007402-tbl-0001"><b>Summary of findings for the main comparison</b> Topical NSAIDs compared with topical placebo for acute musculoskeletal pain in adults</a> </p> <p>Three studies did not contribute data suitable for analysis of at least one outcome (<a href="./references#CD007402-bbs2-0019" title="González de VegaC , SpeedC , WolfarthB , GonzálezJ . Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: a multicentre, randomised, blinded, controlled and non‐inferiority trial. International Journal of Clinical Practice2013;67(10):979‐89. [DOI: 10.1111/ijcp.12219] ">González de Vega 2013</a>; <a href="./references#CD007402-bbs2-0021" title="GualdiA , BonolloL , MartiniA , ForgioneA . Non‐steroidal anti‐inflammatory drugs for topical therapy in traumatology: a double‐blind study with flunoxaprofen and ketoprofen [Antinflammatori no steroidi per uso topico in traumatologia: studio clinico con flunoxaprofene e chetoprofene]. Riforma Medica1987;102(10):401‐4. ">Gualdi 1987</a>; <a href="./references#CD007402-bbs2-0023" title="HoffmannP , KopačkaP , GugliottaB , RovatiS . Efficacy and tolerability of DHEP‐heparin plaster in reducing pain in mild‐to‐moderate muscle contusions: a double‐blind, randomized trial. Current Medical Research and Opinion2012;28(8):1313‐21. [DOI: 10.1185/03007995.2012.709182] ">Hoffmann 2012</a>). </p> <section id="CD007402-sec-0064"> <h4 class="title">1. Topical NSAID versus placebo</h4> <p>Details of efficacy outcomes in individual studies are in <a href="./appendices#CD007402-sec-0118">Appendix 4</a>, and of adverse events and withdrawals in <a href="./appendices#CD007402-sec-0119">Appendix 5</a>. <a href="./appendices#CD007402-sec-0120">Appendix 6</a> has details of the concentration of topical products, the amount applied, the frequency of application, and an estimation of the daily dose of topical NSAID applied. Not all studies provided sufficient information to allow calculation of daily dose applied. For example, for topical diclofenac, the estimated doses applied varied between about 60 and 280 mg; for topical ketoprofen 100 to about 450 mg; for topical ibuprofen 300 to 800 mg. </p> </section> <section id="CD007402-sec-0065"> <h4 class="title">Participants with clinical success</h4> <section id="CD007402-sec-0066"> <h5 class="title">Topical diclofenac versus placebo</h5> <p>Ten studies contributed to this analysis (<a href="./references#CD007402-bbs2-0009" title="CoudreuseJM , deVathaireF . Effect of a plaster containing DHEP and heparin in acute ankle sprains with oedema: a randomized, double‐blind, placebo‐controlled, clinical study. Current Medical Research and Opinion2010;26(9):2221‐8. [DOI: 10.1185/03007995.2010.508020] ">Coudreuse 2010</a>; <a href="./references#CD007402-bbs2-0027" title="JoussellinE . Flector Tissugel for the treatment of painful ankle sprains [Flector Tissugel dans le traitement des entorses douloureuses de la cheville]. Journal de Traumatologie du Sport2003;20:1S5‐9. LionbergerDR , JoussellinE , LanzarottiA , YanchickJ , MagelliM . Diclofenac epolamine topical patch relieves pain associated with ankle sprain. Journal of Pain Research2011;4:47‐53. [DOI: 10.2147/JPR.S15380] LionbergerDR , JoussellinE , YanchickJ , MagelliM , LanzarottiA . Pooled analysis of clinical trial data evaluating the safety and effectiveness of diclofenac epolamine topical patch 1.3% for the treatment of acute ankle sprain. Open Access Journal of Sports Medicine2011;2:75‐84. [DOI: 10.2147/OAJSM.S17048] ">Joussellin 2003</a>; <a href="./references#CD007402-bbs2-0029" title="KlaingutiA , ForgacsA , BerkesI , CastellacciE . A plaster containing DHEP and heparin for mild to moderate contusions and sprains with haematoma: a double‐blind randomized study. Current Medical Research and Opinion2010;26(9):2243‐51. [DOI: 10.1185/03007995.2010.508022] ">Klainguti 2010</a>; <a href="./references#CD007402-bbs2-0032" title="LiC , FrangioneV , RovatiS , ZhengQ . Diclofenac epolamine medicated plaster in the treatment of minor soft tissue injuries: a multicenter randomized controlled trial. Current Medical Research and Opinion2013;29(9):1137‐46. [DOI: 10.1185/03007995.2013.816669] ">Li 2013</a>; <a href="./references#CD007402-bbs2-0046" title="MuellerEA , KirchW , ReiterS . Extent and time course of pain intensity upon treatment with a topical diclofenac sodium patch versus placebo in acute traumatic injury based on a validated end point: post hoc analysis of a randomized placebo‐controlled trial. Expert Opinion on Pharmacotherapy2010;11(4):493‐8. [DOI: 10.1517/14656560903535898] PredelHG , KollR , PabstH , DieterR , GallacchiG , GiannettiB , et al. Diclofenac patch for topical treatment of acute impact injuries: a randomised, double blind, placebo controlled, multicentre study. British Journal of Sports Medicine2004;38(3):318‐23. [DOI: 10.1136/bjsm.2003.005017] ">Predel 2004</a>; <a href="./references#CD007402-bbs2-0047" title="PredelHG , HamelskyS , GoldM , GiannettiB . Efficacy and safety of diclofenac diethylamine 2.32% gel in acute ankle sprain. Medicine and Science in Sports and Exercise2012;44(9):1629‐36. [DOI: 10.1249/MSS.0b013e318257ed41] ">Predel 2012</a>; <a href="./references#CD007402-bbs2-0048" title="PredelHG , GiannettiB , SeigfriedB , NovelliniR , MenkeG . A randomized, double‐blind, placebo‐controlled multicentre study to evaluate the efficacy and safety of diclofenac 4% spray gel in the treatment of acute uncomplicated ankle sprain. Journal of International Medical Research2013;41(4):1187‐202. [DOI: 10.1177/0300060513487639] ">Predel 2013a</a>; <a href="./references#CD007402-bbs2-0049" title="PredelHG , GiannettiB , PabstH , SchaeferA , HugAM , BurnettI . Efficacy and safety of diclofenac diethylamine 1.16% gel in acute neck pain: a randomized, double‐blind, placebo‐controlled study. BMC Musculoskeletal Disorders2013;14:250. [DOI: 10.1186/1471‐2474‐14‐250] ">Predel 2013b</a>; <a href="./references#CD007402-bbs2-0051" title="RowbothamM , GalerB , BlockJ , BackonjaM . Flector Tissugel: efficacy and safety in minor sport injuries. A vs controlled clinical trial. Journal of Sports Traumatology2003;20:IS15‐IS20. ">Rowbotham 2003</a>), of which one (<a href="./references#CD007402-bbs2-0047" title="PredelHG , HamelskyS , GoldM , GiannettiB . Efficacy and safety of diclofenac diethylamine 2.32% gel in acute ankle sprain. Medicine and Science in Sports and Exercise2012;44(9):1629‐36. [DOI: 10.1249/MSS.0b013e318257ed41] ">Predel 2012</a>) had two active treatment arms. A total of 1074 participants were treated with topical diclofenac and 976 with placebo (<a href="./references#CD007402-fig-0007" title="">Analysis 1.1</a>; <a href="#CD007402-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD007402-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Individual NSAID versus placebo, outcome: 2.1 Clinical success." data-id="CD007402-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Individual NSAID versus placebo, outcome: 2.1 Clinical success. </p> </div> </div> </div> <p> <ul id="CD007402-list-0006"> <li> <p>The proportion of participants experiencing successful treatment with topical diclofenac was 74% (800/1074, range 39% to 100%). </p> </li> <li> <p>The proportion of participants experiencing successful treatment with placebo was 47% (461/976, range 8% to 82%). </p> </li> <li> <p>The RR for treatment compared with placebo was 1.6 (95% CI 1.5 to 1.7).</p> </li> <li> <p>The NNT for successful treatment was 3.7 (3.2 to 4.3). For every four participants treated with topical diclofenac, one would experience successful treatment who would not have done so with placebo. </p> </li> </ul> </p> <section id="CD007402-sec-0067"> <h6 class="title">Effect of formulation</h6> <p>The effects of formulation are shown in <a href="./references#CD007402-fig-0009" title="">Analysis 2.1</a> and <a href="#CD007402-fig-0005">Figure 5</a>. </p> <div class="figure" id="CD007402-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="L'Abbé plot of clinical success in studies of topical diclofenac versus topical placebo. The size of the symbol is proportional to the size of the study (inset scale). Dark blue: Emulgel; light blue: spray/gel; red: Flector; pink: other patch or plaster." data-id="CD007402-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>L'Abbé plot of clinical success in studies of topical diclofenac versus topical placebo. The size of the symbol is proportional to the size of the study (inset scale). Dark blue: Emulgel; light blue: spray/gel; red: Flector; pink: other patch or plaster. </p> </div> </div> </div> <p> <ul id="CD007402-list-0007"> <li> <p>Four studies used a Flector® plaster (1030 participants; <a href="./references#CD007402-bbs2-0027" title="JoussellinE . Flector Tissugel for the treatment of painful ankle sprains [Flector Tissugel dans le traitement des entorses douloureuses de la cheville]. Journal de Traumatologie du Sport2003;20:1S5‐9. LionbergerDR , JoussellinE , LanzarottiA , YanchickJ , MagelliM . Diclofenac epolamine topical patch relieves pain associated with ankle sprain. Journal of Pain Research2011;4:47‐53. [DOI: 10.2147/JPR.S15380] LionbergerDR , JoussellinE , YanchickJ , MagelliM , LanzarottiA . Pooled analysis of clinical trial data evaluating the safety and effectiveness of diclofenac epolamine topical patch 1.3% for the treatment of acute ankle sprain. Open Access Journal of Sports Medicine2011;2:75‐84. [DOI: 10.2147/OAJSM.S17048] ">Joussellin 2003</a>; <a href="./references#CD007402-bbs2-0032" title="LiC , FrangioneV , RovatiS , ZhengQ . Diclofenac epolamine medicated plaster in the treatment of minor soft tissue injuries: a multicenter randomized controlled trial. Current Medical Research and Opinion2013;29(9):1137‐46. [DOI: 10.1185/03007995.2013.816669] ">Li 2013</a>; <a href="./references#CD007402-bbs2-0051" title="RowbothamM , GalerB , BlockJ , BackonjaM . Flector Tissugel: efficacy and safety in minor sport injuries. A vs controlled clinical trial. Journal of Sports Traumatology2003;20:IS15‐IS20. ">Rowbotham 2003</a>; <a href="./references#CD007402-bbs2-0053" title="LionbergerDR , JoussellinE , YanchickJ , MagelliM , LanzarottiA . Pooled analysis of clinical trial data evaluating the safety and effectiveness of diclofenac epolamine topical patch 1.3% for the treatment of acute ankle sprain. Open Access Journal of Sports Medicine2011;2:75‐84. [DOI: 10.2147/OAJSM.S17048] SaillantG . Study comparing the efficacy and tolerance of Flector Tissugel® to that of a placebo in the treatment of benign ankle sprains [Étude comparant l’efficacité et la tolérance de FlectorTissugel® à celles d’un placebo dans le traitement des entorses bénignes de la cheville]. Medicine du Sport1998;72:1‐5. ">Saillant 1998</a>). The RR for treatment compared with placebo was 1.5 (1.4 to 1.7), and the NNT was 4.7 (3.7 to 6.5). </p> </li> <li> <p>Three studies used other makes of plaster (474 participants; <a href="./references#CD007402-bbs2-0009" title="CoudreuseJM , deVathaireF . Effect of a plaster containing DHEP and heparin in acute ankle sprains with oedema: a randomized, double‐blind, placebo‐controlled, clinical study. Current Medical Research and Opinion2010;26(9):2221‐8. [DOI: 10.1185/03007995.2010.508020] ">Coudreuse 2010</a>; <a href="./references#CD007402-bbs2-0029" title="KlaingutiA , ForgacsA , BerkesI , CastellacciE . A plaster containing DHEP and heparin for mild to moderate contusions and sprains with haematoma: a double‐blind randomized study. Current Medical Research and Opinion2010;26(9):2243‐51. [DOI: 10.1185/03007995.2010.508022] ">Klainguti 2010</a>; <a href="./references#CD007402-bbs2-0046" title="MuellerEA , KirchW , ReiterS . Extent and time course of pain intensity upon treatment with a topical diclofenac sodium patch versus placebo in acute traumatic injury based on a validated end point: post hoc analysis of a randomized placebo‐controlled trial. Expert Opinion on Pharmacotherapy2010;11(4):493‐8. [DOI: 10.1517/14656560903535898] PredelHG , KollR , PabstH , DieterR , GallacchiG , GiannettiB , et al. Diclofenac patch for topical treatment of acute impact injuries: a randomised, double blind, placebo controlled, multicentre study. British Journal of Sports Medicine2004;38(3):318‐23. [DOI: 10.1136/bjsm.2003.005017] ">Predel 2004</a>). The RR for treatment compared with placebo was 1.6 (1.4 to 1.8), and the NNT was 3.2 (2.6 to 4.2). </p> </li> <li> <p>Two studies used Voltaren Emulgel (314 participants; <a href="./references#CD007402-bbs2-0047" title="PredelHG , HamelskyS , GoldM , GiannettiB . Efficacy and safety of diclofenac diethylamine 2.32% gel in acute ankle sprain. Medicine and Science in Sports and Exercise2012;44(9):1629‐36. [DOI: 10.1249/MSS.0b013e318257ed41] ">Predel 2012</a>; <a href="./references#CD007402-bbs2-0049" title="PredelHG , GiannettiB , PabstH , SchaeferA , HugAM , BurnettI . Efficacy and safety of diclofenac diethylamine 1.16% gel in acute neck pain: a randomized, double‐blind, placebo‐controlled study. BMC Musculoskeletal Disorders2013;14:250. [DOI: 10.1186/1471‐2474‐14‐250] ">Predel 2013b</a>). The RR for treatment compared with placebo was 3.8 (2.7 to 5.5), and the NNT was 1.8 (1.5 to 2.1). </p> </li> <li> <p>One study used a spray gel (232 participants; <a href="./references#CD007402-bbs2-0048" title="PredelHG , GiannettiB , SeigfriedB , NovelliniR , MenkeG . A randomized, double‐blind, placebo‐controlled multicentre study to evaluate the efficacy and safety of diclofenac 4% spray gel in the treatment of acute uncomplicated ankle sprain. Journal of International Medical Research2013;41(4):1187‐202. [DOI: 10.1177/0300060513487639] ">Predel 2013a</a>). The RR for treatment compared with placebo was 1.2 (1.05 to 1.3), and the NNT was 8.0 (4.8 to 24). </p> </li> </ul> </p> <p>Diclofenac as the gel formulation Emulgel was statistically more efficacious than the plaster formulation as Flector plaster (z = 6.360; P value &lt; 0.00001). </p> </section> </section> <section id="CD007402-sec-0068"> <h5 class="title">Topical ibuprofen versus placebo</h5> <p>Five studies contributed to this analysis (<a href="./references#CD007402-bbs2-0005" title="BilligmannPW . Treatment of ankle distortion with ibuprofen gel [Therapie von Sprunggelenks‐distosionen mit ibuprofen‐mikrogel]. Therapiewoche1996;46(21):1187‐92. ">Billigmann 1996</a>; <a href="./references#CD007402-bbs2-0006" title="CampbellJ , DunnT . Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains. Journal of Accident and Emergency Medicine1994;11(3):178‐82. ">Campbell 1994</a>; <a href="./references#CD007402-bbs2-0012" title="DreiserRL . Clinical trial of efficacy and tolerability of topical ibuprofen in the treatment of tendinitis. Le Journal International De Médecine1988;119:15‐31. ">Dreiser 1988</a>; <a href="./references#CD007402-bbs2-0034" title="MachenJ , WhitefieldM . Efficacy of a proprietary ibuprofen gel in soft tissue injuries: a randomised, double blind placebo controlled study. International Journal of Clinical Practice2002;56(2):102‐6. ">Machen 2002</a>; <a href="./references#CD007402-bbs2-0050" title="RameshN , SteuberU . Ibuprofen in a cream vehicle for accidental and sport injuries [Dolgit creme bei unfall‐ und sportverletzungen]. Therapiewoche1983;33:4563‐70. ">Ramesh 1983</a>). A total of 218 participants were treated with topical ibuprofen and 218 with placebo (<a href="./references#CD007402-fig-0007" title="">Analysis 1.1</a>). </p> <p> <ul id="CD007402-list-0008"> <li> <p>The proportion of participants experiencing successful treatment with topical ibuprofen was 55% (120/218, range 31% to 81%). </p> </li> <li> <p>The proportion of participants experiencing successful treatment with placebo was 33% (73/218, range 13% to 76%). </p> </li> <li> <p>The RR of treatment compared with placebo was 1.6 (1.3 to 2.0).</p> </li> <li> <p>The NNT for successful treatment was 4.6 (3.3 to 8.0). For every five participants treated with topical ibuprofen, one would experience successful treatment who would not have done so with placebo. </p> </li> </ul> </p> <section id="CD007402-sec-0069"> <h6 class="title">Effect of formulation</h6> <p>The effects of formulation are shown in <a href="./references#CD007402-fig-0010" title="">Analysis 3.1</a>. </p> <p> <ul id="CD007402-list-0009"> <li> <p>Three studies used cream formulations (195 participants; <a href="./references#CD007402-bbs2-0006" title="CampbellJ , DunnT . Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains. Journal of Accident and Emergency Medicine1994;11(3):178‐82. ">Campbell 1994</a>; <a href="./references#CD007402-bbs2-0012" title="DreiserRL . Clinical trial of efficacy and tolerability of topical ibuprofen in the treatment of tendinitis. Le Journal International De Médecine1988;119:15‐31. ">Dreiser 1988</a>; <a href="./references#CD007402-bbs2-0050" title="RameshN , SteuberU . Ibuprofen in a cream vehicle for accidental and sport injuries [Dolgit creme bei unfall‐ und sportverletzungen]. Therapiewoche1983;33:4563‐70. ">Ramesh 1983</a>). Although this is just below our threshold for pooled analysis, we have included this analysis for completeness and the results should be interpreted with caution. The RR for treatment compared with placebo was 1.3 (1.03 to 1.6), and the NNT was 6.4 (3.4 to 41). </p> </li> <li> <p>Two studies used gel formulations (241 participants; <a href="./references#CD007402-bbs2-0005" title="BilligmannPW . Treatment of ankle distortion with ibuprofen gel [Therapie von Sprunggelenks‐distosionen mit ibuprofen‐mikrogel]. Therapiewoche1996;46(21):1187‐92. ">Billigmann 1996</a>; <a href="./references#CD007402-bbs2-0034" title="MachenJ , WhitefieldM . Efficacy of a proprietary ibuprofen gel in soft tissue injuries: a randomised, double blind placebo controlled study. International Journal of Clinical Practice2002;56(2):102‐6. ">Machen 2002</a>). The RR for treatment compared with placebo was 2.7 (1.7 to 4.2), and the NNT was 3.9 (2.7 to 6.7). </p> </li> </ul> </p> <p>There was no statistically significant difference between the gel and cream formulations (z = 1.160, P value = 0.246). </p> </section> </section> <section id="CD007402-sec-0070"> <h5 class="title">Topical ketoprofen versus placebo</h5> <p>Seven studies contributed to this analysis (<a href="./references#CD007402-bbs2-0001" title="AiraksinenO , VenäläinenJ , PietiläinenT . Ketoprofen 2.5% gel versus placebo gel in the treatment of acute soft tissue injuries. International Journal of Clinical Pharmacology, Therapy and Toxicology1993;31(11):561‐3. ">Airaksinen 1993</a>; <a href="./references#CD007402-bbs2-0013" title="DreiserRL . Clinical trial ‐ Fatsum gel FG‐6. Supplied by Menarini1989. ">Dreiser 1989</a>; <a href="./references#CD007402-bbs2-0028" title="JulienD . Clinical trial ‐ Fastum gel FG‐8. Supplied by Menarini1989. ">Julien 1989</a>; <a href="./references#CD007402-bbs2-0030" title="KockelberghM , VerspeeltP , CaloineR , DermauxF . Local anti inflammatory treatment with a ketoprofen gel: current clinical findings. Journal Belge de Medecine Physique et de Rehabilitation1985;8(4):205‐13. ">Kockelbergh 1985</a>; <a href="./references#CD007402-bbs2-0037" title="MazièresB , RouanetS , GuillonY , ScarsiC , ReinerV . Topical ketoprofen patch in the treatment of tendinitis: a randomized, double blind, placebo controlled study. Journal of Rheumatology2005;32(8):1563‐70. ">Mazières 2005b</a>; <a href="./references#CD007402-bbs2-0036" title="MazièresB , RouanetS , VelicyJ , ScarsiC , ReinerV . Topical ketoprofen patch (100 mg) for the treatment of ankle sprain: a randomized, double‐blind, placebo‐controlled study. American Journal of Sports Medicine2005;33(4):515‐23. [DOI: 10.1177/0363546504268135] ">Mazières 2005a</a>; <a href="./references#CD007402-bbs2-0043" title="NoretA , RotyV , AllingtonN , HautersP , ZuinenC , PoelsR . Ketoprofen gel as topical treatment for sport injuries. Acta Therapeutica1987;13:367‐78. ">Noret 1987</a>). A total of 346 participants were treated with topical ketoprofen, and 337 with placebo (<a href="./references#CD007402-fig-0007" title="">Analysis 1.1</a>). </p> <p> <ul id="CD007402-list-0010"> <li> <p>The proportion of participants experiencing successful treatment with topical ketoprofen was 73% (251/346, range 57% to 89%). </p> </li> <li> <p>The proportion of participants experiencing successful treatment with placebo was 47% (157/337, range 17% to 73%). </p> </li> <li> <p>The RR of treatment compared with placebo was 1.6 (1.4 to 1.8).</p> </li> <li> <p>The NNT for successful treatment was 3.9 (3.0 to 5.3). For every four participants treated with topical ketoprofen, one would experience successful treatment who would not have done so with placebo. </p> </li> </ul> </p> <section id="CD007402-sec-0071"> <h6 class="title">Effect of formulation</h6> <p>The effects of formulation are shown in <a href="./references#CD007402-fig-0011" title="">Analysis 4.1</a> and <a href="#CD007402-fig-0006">Figure 6</a>. </p> <div class="figure" id="CD007402-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="L'Abbé plot of clinical success in studies of topical ketoprofen versus topical placebo. The size of the symbol is proportional to the size of the study (inset scale). Light blue: ketoprofen gel; pink: ketoprofen plaster." data-id="CD007402-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>L'Abbé plot of clinical success in studies of topical ketoprofen versus topical placebo. The size of the symbol is proportional to the size of the study (inset scale). Light blue: ketoprofen gel; pink: ketoprofen plaster. </p> </div> </div> </div> <p>Two studies used a plaster formulation (335 participants; <a href="./references#CD007402-bbs2-0037" title="MazièresB , RouanetS , GuillonY , ScarsiC , ReinerV . Topical ketoprofen patch in the treatment of tendinitis: a randomized, double blind, placebo controlled study. Journal of Rheumatology2005;32(8):1563‐70. ">Mazières 2005b</a>; <a href="./references#CD007402-bbs2-0036" title="MazièresB , RouanetS , VelicyJ , ScarsiC , ReinerV . Topical ketoprofen patch (100 mg) for the treatment of ankle sprain: a randomized, double‐blind, placebo‐controlled study. American Journal of Sports Medicine2005;33(4):515‐23. [DOI: 10.1177/0363546504268135] ">Mazières 2005a</a>). The RR for treatment compared with placebo was 1.2 (1.04 to 1.4), and the NNT was 8.2 (4.5 to 47). </p> <p>Five studies used gel formulations (348 participants; <a href="./references#CD007402-bbs2-0001" title="AiraksinenO , VenäläinenJ , PietiläinenT . Ketoprofen 2.5% gel versus placebo gel in the treatment of acute soft tissue injuries. International Journal of Clinical Pharmacology, Therapy and Toxicology1993;31(11):561‐3. ">Airaksinen 1993</a>; <a href="./references#CD007402-bbs2-0013" title="DreiserRL . Clinical trial ‐ Fatsum gel FG‐6. Supplied by Menarini1989. ">Dreiser 1989</a>; <a href="./references#CD007402-bbs2-0028" title="JulienD . Clinical trial ‐ Fastum gel FG‐8. Supplied by Menarini1989. ">Julien 1989</a>; <a href="./references#CD007402-bbs2-0030" title="KockelberghM , VerspeeltP , CaloineR , DermauxF . Local anti inflammatory treatment with a ketoprofen gel: current clinical findings. Journal Belge de Medecine Physique et de Rehabilitation1985;8(4):205‐13. ">Kockelbergh 1985</a>; <a href="./references#CD007402-bbs2-0043" title="NoretA , RotyV , AllingtonN , HautersP , ZuinenC , PoelsR . Ketoprofen gel as topical treatment for sport injuries. Acta Therapeutica1987;13:367‐78. ">Noret 1987</a>). The RR for treatment compared with placebo was 2.2 (1.7 to 2.8), and the NNT was 2.5 (2.0 to 3.4). </p> <p>Ketoprofen as a gel formulation was statistically more efficacious than a plaster formulation (z = 3.860, P value = 0.00014). </p> </section> </section> <section id="CD007402-sec-0072"> <h5 class="title">Topical piroxicam versus placebo</h5> <p>Three studies contributed to this analysis (<a href="./references#CD007402-bbs2-0003" title="AokiT , NumajiriM , YamamotoM . A well controlled comparative study of piroxicam gel, indomethacin gel and placebo gel in the treatment of trauma. Japanese Pharmacology and Therapeutics1984;12(12):101‐17. ">Aoki 1984</a>; <a href="./references#CD007402-bbs2-0017" title="FujimakiE , et al. Clinical evaluation of piroxicam gel versus indomethacin gel and placebo in the treatment of muscle pain: a double‐blind, multicenter study. Japanese Pharmacology and Therapeutics1985;12(12):119‐37. ">Fujimaki 1985</a>; <a href="./references#CD007402-bbs2-0052" title="RussellAL . Piroxicam 0.5% topical gel compared to placebo in the treatment of acute soft tissue injuries: a double‐blind study comparing efficacy and safety. Clinical and Investigative Medicine1991;14(1):35‐43. ">Russell 1991</a>). A total of 255 participants were treated with topical piroxicam, and 249 with placebo (<a href="./references#CD007402-fig-0007" title="">Analysis 1.1</a>). </p> <p> <ul id="CD007402-list-0011"> <li> <p>The proportion of participants experiencing successful treatment with topical piroxicam was 68% (179/255, range 53% to 79%). </p> </li> <li> <p>The proportion of participants experiencing successful treatment with placebo was 47% (118/249, range 45% to 49%). </p> </li> <li> <p>The RR of treatment compared with placebo was 1.5 (1.3 to 1.7).</p> </li> <li> <p>The NNT for successful treatment was 4.4 (3.2 to 6.9). For every four participants treated with topical piroxicam, one would experience successful treatment who would not have done so with placebo. </p> </li> </ul> </p> </section> <section id="CD007402-sec-0073"> <h5 class="title">Topical indomethacin versus placebo</h5> <p>Three studies contributed to this analysis (<a href="./references#CD007402-bbs2-0002" title="ĂkermarkC , ForsskåhlB . Topical indomethacin in overuse injuries in athletes. A randomized double blind study comparing Elmetacin® with oral indomethacin and placebo. International Journal of Sports Medicine1990;11(5):393‐6. ">Ăkermark 1990</a>; <a href="./references#CD007402-bbs2-0003" title="AokiT , NumajiriM , YamamotoM . A well controlled comparative study of piroxicam gel, indomethacin gel and placebo gel in the treatment of trauma. Japanese Pharmacology and Therapeutics1984;12(12):101‐17. ">Aoki 1984</a>; <a href="./references#CD007402-bbs2-0017" title="FujimakiE , et al. Clinical evaluation of piroxicam gel versus indomethacin gel and placebo in the treatment of muscle pain: a double‐blind, multicenter study. Japanese Pharmacology and Therapeutics1985;12(12):119‐37. ">Fujimaki 1985</a>). A total of 168 participants were treated with topical indomethacin, and 173 with placebo (<a href="./references#CD007402-fig-0007" title="">Analysis 1.1</a>). </p> <p> <ul id="CD007402-list-0012"> <li> <p>The proportion of participants experiencing successful treatment with topical indomethacin was 58% (97/168, range 54% to 64%). </p> </li> <li> <p>The proportion of participants experiencing successful treatment with placebo was 46% (79/173, range 25% to 49%). </p> </li> <li> <p>The RR of treatment compared with placebo was 1.3 (1.03 to 1.6).</p> </li> <li> <p>The NNT for successful treatment was 8.3 (4.4 to 65). For every eight participants treated with topical indomethacin, one would experience successful treatment who would not have done so with placebo. </p> </li> </ul> </p> </section> <section id="CD007402-sec-0074"> <h5 class="title">Topical benzydamine versus placebo</h5> <p>Three studies contributed to this analysis (<a href="./references#CD007402-bbs2-0007" title="ChatterjeeDS . A double‐blind clinical study with benzydamine 3% cream on soft tissue injuries in an occupational health centre. Journal of International Medical Research1977;5(6):450‐8. ">Chatterjee 1977</a>; <a href="./references#CD007402-bbs2-0022" title="HaigG . Portable thermogram technique for topically applied benzydamine cream in acute soft‐tissue injuries. Internation Journal of Tissue Reactions1986;8(2):145‐7. ">Haig 1986</a>; <a href="./references#CD007402-bbs2-0033" title="LindeF , HvassI , JürgensenU , MadsenF . Treatment of sprained ankles with 5% benzydamine creme. A double‐blind study [Ankelforstuvninger behandlet med benzydamin 5% creme]. Ugeskrift for Laeger1985;148(1):12‐3. ">Linde 1985</a>). A total of 96 participants were treated with topical benzydamine, and 97 with placebo (<a href="./references#CD007402-fig-0007" title="">Analysis 1.1</a>). Although this is just below our threshold for pooled analysis, we have included this analysis for completeness and the results should be interpreted with caution. </p> <p> <ul id="CD007402-list-0013"> <li> <p>The proportion of participants experiencing successful treatment with topical benzydamine was 77% (74/96, range 70% to 86%). </p> </li> <li> <p>The proportion of participants experiencing successful treatment with placebo was 67% (65/97, range 48% to 80%). </p> </li> <li> <p>The RR of treatment compared with placebo was 1.2 (0.96 to 1.4). There was no statistically significant difference between treatments (<a href="#CD007402-fig-0004">Figure 4</a>). </p> </li> </ul> </p> <p>Results for participants with clinical success with individual topical NSAIDs, where there were adequate data for analysis, are summarised below in 'Summary of results A' and <a href="./references#CD007402-fig-0007" title="">Analysis 1.1</a>, <a href="./references#CD007402-fig-0009" title="">Analysis 2.1</a>, <a href="./references#CD007402-fig-0010" title="">Analysis 3.1</a>, and <a href="./references#CD007402-fig-0011" title="">Analysis 4.1</a>. </p> <p> <div class="table" id="CD007402-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Summary of results A: Participants with clinical success</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Studies</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NSAID</b> </p> <p><b>(%)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo (%)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Relative benefit (95% CI)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NNT (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diclofenac ‐ Flector plaster</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1030</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5 (1.4 to 1.7)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.7 (3.7 to 6.5)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diclofenac ‐ other plaster</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>474</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.6 (1.4 to 1.8)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.2 (2.6 to 4.2)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diclofenac ‐ Emulgel</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>314</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8 (2.7 to 5.5)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.8 (1.5 to 2.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diclofenac ‐ other gel*</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>232</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2 (1.1 to 1.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.0 (4.8 to 24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibuprofen ‐ cream*</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>195</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.3 (1.03 to 1.6)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.4 (3.4 to 41)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibuprofen ‐ gel</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>241</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.7 (1.7 to 4.2)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.9 (2.7 to 6.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ketoprofen ‐ plaster</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>335</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2 (1.04 to 1.4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.2 (4.5 to 47)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ketoprofen ‐ gel</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>348</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.2 (1.7 to 2.8)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.5 (2.0 to 3.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Piroxicam</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>504</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5 (1.3 to 1.7)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.4 (3.2 to 6.9)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Indomethacin</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>341</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.3 (1.03 to 1.6)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.3 (4.4 to 65)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Benzydamine*</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>193</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2 (0.96 to 1.4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>not calculated</p> </td> </tr> </tbody> </table> </div> </p> <p>* Results for these two comparisons are derived from very small amounts of data and are provided here for completeness. They should be interpreted with caution. </p> </section> </section> <section id="CD007402-sec-0075"> <h4 class="title">Local adverse events</h4> <p>Local adverse events were irritation of the area to which the topical NSAID was applied, including redness or erythema and itch or pruritus. Where reported, these were usually described as mild and transient. </p> <section id="CD007402-sec-0076"> <h5 class="title">All topical NSAIDs versus placebo</h5> <p>Forty‐two studies contributed to this analysis, of which three compared two different drugs with placebo (<a href="./references#CD007402-bbs2-0003" title="AokiT , NumajiriM , YamamotoM . A well controlled comparative study of piroxicam gel, indomethacin gel and placebo gel in the treatment of trauma. Japanese Pharmacology and Therapeutics1984;12(12):101‐17. ">Aoki 1984</a>; <a href="./references#CD007402-bbs2-0011" title="DiebschlagW , NockerW , BullinghamR . A double‐blind study of the efficacy of topical ketorolac tromethamine gel in the treatment of ankle sprain, in comparison to placebo and etofenamate. Journal of Clinical Pharmacology1990;30(1):82‐9. ">Diebshlag 1990</a>; <a href="./references#CD007402-bbs2-0017" title="FujimakiE , et al. Clinical evaluation of piroxicam gel versus indomethacin gel and placebo in the treatment of muscle pain: a double‐blind, multicenter study. Japanese Pharmacology and Therapeutics1985;12(12):119‐37. ">Fujimaki 1985</a>). Three studies had two treatment arms comparing different formulations or application regimens for diclofenac with placebo, which have been combined for this analysis (<a href="./references#CD007402-bbs2-0008" title="CostantinoC , KwareckiJ , SamokhinAV , MautoneG , RovatiS . Diclofenac epolamine plus heparin plaster versus diclofenac epolamine plaster in mild to moderate ankle sprain: a randomized, double‐blind, parallel‐group, placebo‐controlled, multicentre, phase III trial. Clinical Drug Investigation2011;31(1):15‐26. [DOI: 10.2165/11585890‐000000000‐00000] ">Costantino 2011</a>; <a href="./references#CD007402-bbs2-0029" title="KlaingutiA , ForgacsA , BerkesI , CastellacciE . A plaster containing DHEP and heparin for mild to moderate contusions and sprains with haematoma: a double‐blind randomized study. Current Medical Research and Opinion2010;26(9):2243‐51. [DOI: 10.1185/03007995.2010.508022] ">Klainguti 2010</a>; <a href="./references#CD007402-bbs2-0047" title="PredelHG , HamelskyS , GoldM , GiannettiB . Efficacy and safety of diclofenac diethylamine 2.32% gel in acute ankle sprain. Medicine and Science in Sports and Exercise2012;44(9):1629‐36. [DOI: 10.1249/MSS.0b013e318257ed41] ">Predel 2012</a>). In total, 3619 participants were treated with topical NSAIDs and 3121 with placebo (<a href="./references#CD007402-fig-0012" title="">Analysis 5.1</a>). </p> <p> <ul id="CD007402-list-0014"> <li> <p>The proportion of participants experiencing a local adverse event with a topical NSAID was 4.3% (155/3619, range 0% to 33%). </p> </li> <li> <p>The proportion of participants experiencing a local adverse event with placebo was 4.6% (145/3121, range 0% to 32%). </p> </li> <li> <p>The RR of topical NSAID compared with placebo was 0.98 (0.80 to 1.2).</p> </li> <li> <p>There was no significant difference between treatment groups so the NNH was not calculated.</p> </li> </ul> </p> </section> <section id="CD007402-sec-0077"> <h5 class="title">Individual topical NSAIDs versus placebo</h5> <p>Results for local adverse events with individual topical NSAIDs, where there were adequate data for analysis, are in Summary of results B and <a href="./references#CD007402-fig-0008" title="">Analysis 1.2</a>. </p> <p> <div class="table" id="CD007402-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Summary of results B: Participants with local adverse events</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Studies</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NSAID</b> </p> <p><b>(%)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo</b> </p> <p><b>(%)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR</b> </p> <p><b>(95% CI)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NNH</b> </p> <p><b>(95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All NSAIDs</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6740</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.98 (0.80 to 1.2)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diclofenac</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3271</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.78 (0.56 to 1.1)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ketoprofen</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>852</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2 (0.83 to 1.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Piroxicam</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>522</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.42 (0.17 to 1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Felbinac</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>397</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.9 (0.49 to 7.5)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Indomethacin</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>354</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.7 (0.91 to 7.7)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibuprofen</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>321</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.3 (0.98 to 5.4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> </tr> </tbody> </table> </div> </p> </section> </section> <section id="CD007402-sec-0078"> <h4 class="title">Systemic adverse events</h4> <section id="CD007402-sec-0079"> <h5 class="title">All topical NSAIDs versus placebo</h5> <p>Thirty‐six studies contributed data on systemic adverse events, of which three compared two different drugs with placebo (<a href="./references#CD007402-bbs2-0003" title="AokiT , NumajiriM , YamamotoM . A well controlled comparative study of piroxicam gel, indomethacin gel and placebo gel in the treatment of trauma. Japanese Pharmacology and Therapeutics1984;12(12):101‐17. ">Aoki 1984</a>; <a href="./references#CD007402-bbs2-0011" title="DiebschlagW , NockerW , BullinghamR . A double‐blind study of the efficacy of topical ketorolac tromethamine gel in the treatment of ankle sprain, in comparison to placebo and etofenamate. Journal of Clinical Pharmacology1990;30(1):82‐9. ">Diebshlag 1990</a>; <a href="./references#CD007402-bbs2-0017" title="FujimakiE , et al. Clinical evaluation of piroxicam gel versus indomethacin gel and placebo in the treatment of muscle pain: a double‐blind, multicenter study. Japanese Pharmacology and Therapeutics1985;12(12):119‐37. ">Fujimaki 1985</a>). Two studies had two treatment arms comparing different formulations or application regimens for diclofenac with placebo, which have been combined for this analysis (<a href="./references#CD007402-bbs2-0029" title="KlaingutiA , ForgacsA , BerkesI , CastellacciE . A plaster containing DHEP and heparin for mild to moderate contusions and sprains with haematoma: a double‐blind randomized study. Current Medical Research and Opinion2010;26(9):2243‐51. [DOI: 10.1185/03007995.2010.508022] ">Klainguti 2010</a>; <a href="./references#CD007402-bbs2-0047" title="PredelHG , HamelskyS , GoldM , GiannettiB . Efficacy and safety of diclofenac diethylamine 2.32% gel in acute ankle sprain. Medicine and Science in Sports and Exercise2012;44(9):1629‐36. [DOI: 10.1249/MSS.0b013e318257ed41] ">Predel 2012</a>). In total, 2956 participants were treated with a topical NSAID and 2620 with placebo (<a href="./references#CD007402-fig-0013" title="">Analysis 5.2</a>). </p> <p> <ul id="CD007402-list-0015"> <li> <p>Twenty‐three studies reported no systemic adverse events in any arm of the study.</p> </li> <li> <p>The proportion of participants experiencing a systemic adverse event with a topical NSAID was 3.1% (92/2956). </p> </li> <li> <p>The proportion of participants experiencing a systemic adverse event with placebo was 3.5% (91/2620). </p> </li> <li> <p>The RR of topical NSAID compared with placebo was 0.96 (0.73 to 1.3).</p> </li> <li> <p>There was no significant difference between treatment groups so the NNH was not calculated.</p> </li> </ul> </p> <p>A further six studies did not report the occurrence or otherwise of systemic adverse events (<a href="./references#CD007402-bbs2-0005" title="BilligmannPW . Treatment of ankle distortion with ibuprofen gel [Therapie von Sprunggelenks‐distosionen mit ibuprofen‐mikrogel]. Therapiewoche1996;46(21):1187‐92. ">Billigmann 1996</a>; <a href="./references#CD007402-bbs2-0028" title="JulienD . Clinical trial ‐ Fastum gel FG‐8. Supplied by Menarini1989. ">Julien 1989</a>; <a href="./references#CD007402-bbs2-0030" title="KockelberghM , VerspeeltP , CaloineR , DermauxF . Local anti inflammatory treatment with a ketoprofen gel: current clinical findings. Journal Belge de Medecine Physique et de Rehabilitation1985;8(4):205‐13. ">Kockelbergh 1985</a>; <a href="./references#CD007402-bbs2-0043" title="NoretA , RotyV , AllingtonN , HautersP , ZuinenC , PoelsR . Ketoprofen gel as topical treatment for sport injuries. Acta Therapeutica1987;13:367‐78. ">Noret 1987</a>; <a href="./references#CD007402-bbs2-0050" title="RameshN , SteuberU . Ibuprofen in a cream vehicle for accidental and sport injuries [Dolgit creme bei unfall‐ und sportverletzungen]. Therapiewoche1983;33:4563‐70. ">Ramesh 1983</a>; <a href="./references#CD007402-bbs2-0060" title="VecchietL , ColozziA . Effects of meclofenamic acid in the treatment of lesions deriving from minor traumatology. Clinical Journal of Pain1991;7 Suppl 1:S54‐9. ">Vecchiet 1991</a>), while two studies did not report numbers of participants with systemic adverse events (<a href="./references#CD007402-bbs2-0002" title="ĂkermarkC , ForsskåhlB . Topical indomethacin in overuse injuries in athletes. A randomized double blind study comparing Elmetacin® with oral indomethacin and placebo. International Journal of Sports Medicine1990;11(5):393‐6. ">Ăkermark 1990</a>; <a href="./references#CD007402-bbs2-0004" title="AuclairJ , GeorgesM , GraptonX , GrypL , D'HoogheM , MeisserRG , et al. A double‐blind controlled multi‐center study of percutaneous niflumic acid gel and placebo in the treatment of Achilles heel tendinitis. Current Therapeutic Research1989;46(4):782‐8. ">Auclair 1989</a>). <a href="./references#CD007402-bbs2-0008" title="CostantinoC , KwareckiJ , SamokhinAV , MautoneG , RovatiS . Diclofenac epolamine plus heparin plaster versus diclofenac epolamine plaster in mild to moderate ankle sprain: a randomized, double‐blind, parallel‐group, placebo‐controlled, multicentre, phase III trial. Clinical Drug Investigation2011;31(1):15‐26. [DOI: 10.2165/11585890‐000000000‐00000] ">Costantino 2011</a> reported that there were no systemic gastrointestinal adverse events. Two studies reported only on total adverse events, without distinguishing between local and systemic events (<a href="./references#CD007402-bbs2-0040" title="Novartis(Sponsors) . A randomized, double‐blind, multi‐center, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied 4 times daily in subjects with acute ankle sprain. clinicaltrials.gov/ct2/show/NCT01255423 (accessed 3 February 2015)2012. [CTG: NCT01255423] ">NCT01255423</a>; <a href="./references#CD007402-bbs2-0041" title="Novartis(Sponsors) . A randomized, double‐blind, multi‐center, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied four times daily in subjects with acute ankle sprain. clinicaltrials.gov/ct2/show/results/NCT01272934 (accessed 3 February 2015)2013. [CTG: NCT01272934] ">NCT01272934</a>). </p> </section> </section> <section id="CD007402-sec-0080"> <h4 class="title">Serious adverse events</h4> <p>Two studies reported serious adverse events. In <a href="./references#CD007402-bbs2-0023" title="HoffmannP , KopačkaP , GugliottaB , RovatiS . Efficacy and tolerability of DHEP‐heparin plaster in reducing pain in mild‐to‐moderate muscle contusions: a double‐blind, randomized trial. Current Medical Research and Opinion2012;28(8):1313‐21. [DOI: 10.1185/03007995.2012.709182] ">Hoffmann 2012</a>, one participant experienced three serious adverse events, none of which was judged to be related to the study medication (diclofenac plaster). In <a href="./references#CD007402-bbs2-0041" title="Novartis(Sponsors) . A randomized, double‐blind, multi‐center, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied four times daily in subjects with acute ankle sprain. clinicaltrials.gov/ct2/show/results/NCT01272934 (accessed 3 February 2015)2013. [CTG: NCT01272934] ">NCT01272934</a>, one participant using diclofenac gel ruptured the ligaments of the wrist. There was no statement about likely relationship to the study medication, but this seems unlikely. </p> </section> <section id="CD007402-sec-0081"> <h4 class="title">Adverse event withdrawals</h4> <p>Forty‐two studies reported data relating to adverse event withdrawals, of which three compared two different drugs with placebo (<a href="./references#CD007402-bbs2-0003" title="AokiT , NumajiriM , YamamotoM . A well controlled comparative study of piroxicam gel, indomethacin gel and placebo gel in the treatment of trauma. Japanese Pharmacology and Therapeutics1984;12(12):101‐17. ">Aoki 1984</a>; <a href="./references#CD007402-bbs2-0011" title="DiebschlagW , NockerW , BullinghamR . A double‐blind study of the efficacy of topical ketorolac tromethamine gel in the treatment of ankle sprain, in comparison to placebo and etofenamate. Journal of Clinical Pharmacology1990;30(1):82‐9. ">Diebshlag 1990</a>; <a href="./references#CD007402-bbs2-0017" title="FujimakiE , et al. Clinical evaluation of piroxicam gel versus indomethacin gel and placebo in the treatment of muscle pain: a double‐blind, multicenter study. Japanese Pharmacology and Therapeutics1985;12(12):119‐37. ">Fujimaki 1985</a>). Two studies had two treatment arms comparing different formulations or application regimens for diclofenac with placebo, which have been combined for this analysis (<a href="./references#CD007402-bbs2-0029" title="KlaingutiA , ForgacsA , BerkesI , CastellacciE . A plaster containing DHEP and heparin for mild to moderate contusions and sprains with haematoma: a double‐blind randomized study. Current Medical Research and Opinion2010;26(9):2243‐51. [DOI: 10.1185/03007995.2010.508022] ">Klainguti 2010</a>; <a href="./references#CD007402-bbs2-0047" title="PredelHG , HamelskyS , GoldM , GiannettiB . Efficacy and safety of diclofenac diethylamine 2.32% gel in acute ankle sprain. Medicine and Science in Sports and Exercise2012;44(9):1629‐36. [DOI: 10.1249/MSS.0b013e318257ed41] ">Predel 2012</a>). In total, 3365 participants received a topical NSAID and 3040 placebo (<a href="./references#CD007402-fig-0014" title="">Analysis 5.3</a>). </p> <p> <ul id="CD007402-list-0016"> <li> <p>Forty‐four comparisons reported no adverse event withdrawals.</p> </li> <li> <p>The proportion of participants withdrawing from the study due to an adverse event after treatment with a topical NSAID was 0.98% (33/3365). </p> </li> <li> <p>The proportion of participants withdrawing from the study due to an adverse event after treatment with placebo was 0.99% (30/3040). </p> </li> <li> <p>The RR of topical NSAID compared to placebo was 1.0 (0.64 to 1.6).</p> </li> <li> <p>There was no significant difference between treatment groups so the NNH was not calculated.</p> </li> </ul> </p> <p>Four studies did not specifically mention adverse event withdrawals (<a href="./references#CD007402-bbs2-0022" title="HaigG . Portable thermogram technique for topically applied benzydamine cream in acute soft‐tissue injuries. Internation Journal of Tissue Reactions1986;8(2):145‐7. ">Haig 1986</a>; <a href="./references#CD007402-bbs2-0023" title="HoffmannP , KopačkaP , GugliottaB , RovatiS . Efficacy and tolerability of DHEP‐heparin plaster in reducing pain in mild‐to‐moderate muscle contusions: a double‐blind, randomized trial. Current Medical Research and Opinion2012;28(8):1313‐21. [DOI: 10.1185/03007995.2012.709182] ">Hoffmann 2012</a>; <a href="./references#CD007402-bbs2-0029" title="KlaingutiA , ForgacsA , BerkesI , CastellacciE . A plaster containing DHEP and heparin for mild to moderate contusions and sprains with haematoma: a double‐blind randomized study. Current Medical Research and Opinion2010;26(9):2243‐51. [DOI: 10.1185/03007995.2010.508022] ">Klainguti 2010</a>; <a href="./references#CD007402-bbs2-0060" title="VecchietL , ColozziA . Effects of meclofenamic acid in the treatment of lesions deriving from minor traumatology. Clinical Journal of Pain1991;7 Suppl 1:S54‐9. ">Vecchiet 1991</a>), while one reported that one participant withdrew with mild pruritus, but did not state the treatment arm (<a href="./references#CD007402-bbs2-0027" title="JoussellinE . Flector Tissugel for the treatment of painful ankle sprains [Flector Tissugel dans le traitement des entorses douloureuses de la cheville]. Journal de Traumatologie du Sport2003;20:1S5‐9. LionbergerDR , JoussellinE , LanzarottiA , YanchickJ , MagelliM . Diclofenac epolamine topical patch relieves pain associated with ankle sprain. Journal of Pain Research2011;4:47‐53. [DOI: 10.2147/JPR.S15380] LionbergerDR , JoussellinE , YanchickJ , MagelliM , LanzarottiA . Pooled analysis of clinical trial data evaluating the safety and effectiveness of diclofenac epolamine topical patch 1.3% for the treatment of acute ankle sprain. Open Access Journal of Sports Medicine2011;2:75‐84. [DOI: 10.2147/OAJSM.S17048] ">Joussellin 2003</a>). </p> <p>Ten studies specifically reported withdrawals due to lack of efficacy (<a href="./references#CD007402-bbs2-0013" title="DreiserRL . Clinical trial ‐ Fatsum gel FG‐6. Supplied by Menarini1989. ">Dreiser 1989</a>; <a href="./references#CD007402-bbs2-0015" title="DreiserRL , RocheR , deSahbR , ThomasF , LeuteneggerE . Flurbiprofen local action transcutaneous (LAT tm): clinical evaluation in the treatment of acute ankle sprains. European Journal of Rheumatology and Inflammation1994;14(4):9‐13. ">Dreiser 1994</a>; <a href="./references#CD007402-bbs2-0031" title="KuehlK , CarrW , YanchickJ , MagelliM , RovatiS . Analgesic efficacy and safety of the diclofenac epolamine topical patch 1.3% (DETP) in minor soft tissue injury. International Journal of Sports Medicine2011;32(8):635‐43. [DOI: 10.1055/s‐0031‐1275359] ">Kuehl 2011</a>; <a href="./references#CD007402-bbs2-0034" title="MachenJ , WhitefieldM . Efficacy of a proprietary ibuprofen gel in soft tissue injuries: a randomised, double blind placebo controlled study. International Journal of Clinical Practice2002;56(2):102‐6. ">Machen 2002</a>; <a href="./references#CD007402-bbs2-0037" title="MazièresB , RouanetS , GuillonY , ScarsiC , ReinerV . Topical ketoprofen patch in the treatment of tendinitis: a randomized, double blind, placebo controlled study. Journal of Rheumatology2005;32(8):1563‐70. ">Mazières 2005b</a>; <a href="./references#CD007402-bbs2-0036" title="MazièresB , RouanetS , VelicyJ , ScarsiC , ReinerV . Topical ketoprofen patch (100 mg) for the treatment of ankle sprain: a randomized, double‐blind, placebo‐controlled study. American Journal of Sports Medicine2005;33(4):515‐23. [DOI: 10.1177/0363546504268135] ">Mazières 2005a</a>; <a href="./references#CD007402-bbs2-0043" title="NoretA , RotyV , AllingtonN , HautersP , ZuinenC , PoelsR . Ketoprofen gel as topical treatment for sport injuries. Acta Therapeutica1987;13:367‐78. ">Noret 1987</a>; <a href="./references#CD007402-bbs2-0048" title="PredelHG , GiannettiB , SeigfriedB , NovelliniR , MenkeG . A randomized, double‐blind, placebo‐controlled multicentre study to evaluate the efficacy and safety of diclofenac 4% spray gel in the treatment of acute uncomplicated ankle sprain. Journal of International Medical Research2013;41(4):1187‐202. [DOI: 10.1177/0300060513487639] ">Predel 2013a</a>; <a href="./references#CD007402-bbs2-0052" title="RussellAL . Piroxicam 0.5% topical gel compared to placebo in the treatment of acute soft tissue injuries: a double‐blind study comparing efficacy and safety. Clinical and Investigative Medicine1991;14(1):35‐43. ">Russell 1991</a>; <a href="./references#CD007402-bbs2-0058" title="ThorlingJ , LindenB , BergR , SandahlA . A double blind comparison of naproxen gel and placebo in the treatment of soft tissue injuries. Current Medical Research and Opinion1990;12:242‐8. ">Thorling 1990</a>) (<a href="./appendices#CD007402-sec-0119">Appendix 5</a>). Numbers of participants withdrawing were generally low, with rates of 6% or less, except in <a href="./references#CD007402-bbs2-0031" title="KuehlK , CarrW , YanchickJ , MagelliM , RovatiS . Analgesic efficacy and safety of the diclofenac epolamine topical patch 1.3% (DETP) in minor soft tissue injury. International Journal of Sports Medicine2011;32(8):635‐43. [DOI: 10.1055/s‐0031‐1275359] ">Kuehl 2011</a>, where the rate was 10% with active treatment (diclofenac plaster) and 12% with placebo. We did not carry out any analysis because the outcome was inconsistently reported. </p> </section> <section id="CD007402-sec-0082"> <h4 class="title">2. Topical NSAID versus active comparator</h4> <p>Details of efficacy outcomes in individual studies are in <a href="./appendices#CD007402-sec-0118">Appendix 4</a>, and of adverse events and withdrawals in <a href="./appendices#CD007402-sec-0119">Appendix 5</a>. </p> </section> <section id="CD007402-sec-0083"> <h4 class="title">Participants with clinical success</h4> <section id="CD007402-sec-0084"> <h5 class="title">Topical NSAID versus oral NSAID</h5> <p> <ul id="CD007402-list-0017"> <li> <p><a href="./references#CD007402-bbs2-0002" title="ĂkermarkC , ForsskåhlB . Topical indomethacin in overuse injuries in athletes. A randomized double blind study comparing Elmetacin® with oral indomethacin and placebo. International Journal of Sports Medicine1990;11(5):393‐6. ">Ăkermark 1990</a> compared indomethacin spray with indomethacin capsules, with response rates of 55% (12/22) with spray and 23% (5/22) with capsules. </p> </li> <li> <p><a href="./references#CD007402-bbs2-0025" title="HosieGAC . The topical NSAID, felbinac, versus oral ibuprofen: a comparison of efficacy in the treatment of acute lower back injury. British Journal of Clinical Research1993;4:5‐17. ">Hosie 1993</a> compared felbinac foam with ibuprofen tablets, with response rates of 64% (81/127) with felbinac foam and 72% (96/133) with ibuprofen tablets. </p> </li> <li> <p><a href="./references#CD007402-bbs2-0061" title="WhitefieldM , O'KaneCJA , AndersonS . Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomised, double blind study. Journal of Clinical Pharmacy and Therapeutics2002;27(6):409‐17. ">Whitefield 2002</a> compared ibuprofen gel with ibuprofen tablets, with response rates of 60% (30/50) with gel and 54% (36/50) with tablets. </p> </li> </ul> </p> <p>There were insufficient data for meta‐analysis for any one of these comparisons; felbinac is not known to be better than placebo. </p> </section> <section id="CD007402-sec-0085"> <h5 class="title">Topical NSAID versus different formulation of the same topical NSAID</h5> <p> <ul id="CD007402-list-0018"> <li> <p><a href="./references#CD007402-bbs2-0016" title="FioravantiA , CiceroMR , NerucciF , ManopuloR , MarcolongoR . Double‐blind controlled clinical study of the efficacy and tolerability of diclofenac‐N‐(2‐hydroxyethyl)‐pyrrolidine lecithin gel compared with diclofenac‐N‐(2‐hydroxyethyl)‐pyrrolidine gel in patients with peri and extraarticular inflammatory diseases. Drugs under Experimental and Clinical Research1999;25(5):235‐40. ">Fioravanti 1999</a> compared DHEP (diclofenac) gel formulated with and without lecithin, with response rates of 70% (35/50) in both treatment arms. </p> </li> <li> <p><a href="./references#CD007402-bbs2-0035" title="MahlerP , MahlerF , DuruzH , RamazzinaM , LiguoriV , MautoneG . Double‐blind, randomized, controlled study on the efficacy and safety of a novel diclofenac epolamine gel formulated with lecithin for the treatment of sprains, strains and contusions. Drugs under Experimental and Clinical Research2003;29(1):45‐52. ">Mahler 2003</a> compared DHEP (diclofenac) gel formulated with and without lecithin, with response rates of 89% (82/92) with lecithin and 70% (62/88) without lecithin. </p> </li> <li> <p><a href="./references#CD007402-bbs2-0018" title="GallacchiG , MautoneG , LauldiP . Topical treatment with diclofenac hydroxyethylpyrrilidine (Flector gel 1%). Clinical Trials Journal1990;27(1):58‐64. ">Gallacchi 1990</a> compared topical diclofenac formulated as Flector® gel and Emugel®, with response rates of 76% (19/25) in both treatment arms </p> </li> <li> <p><a href="./references#CD007402-bbs2-0020" title="GovernaliE , CasaliniD . A controlled clinical study on ketoprofen gel 5% versus ketoprofen ointment 1% in patients with post‐traumatic lesions [Ricerda clinica controllata tra ketoprofene gel 5% e ketoprofene crema 1% in pazienti con postumi di lesioni traumatiche]. Riabilitazione1995;28(1):61‐9. ">Governali 1995</a> compared topical ketoprofen cream with gel, with response rates of 93% (14/15) with cream and 27% (4/15) with gel. </p> </li> </ul> </p> <p>There were insufficient data for analysis.</p> </section> <section id="CD007402-sec-0086"> <h5 class="title">Topical NSAID versus different topical NSAID</h5> <p>Eight studies compared one topical NSAID versus at least one other topical NSAID: piroxicam versus indomethacin (<a href="./references#CD007402-bbs2-0003" title="AokiT , NumajiriM , YamamotoM . A well controlled comparative study of piroxicam gel, indomethacin gel and placebo gel in the treatment of trauma. Japanese Pharmacology and Therapeutics1984;12(12):101‐17. ">Aoki 1984</a>; <a href="./references#CD007402-bbs2-0017" title="FujimakiE , et al. Clinical evaluation of piroxicam gel versus indomethacin gel and placebo in the treatment of muscle pain: a double‐blind, multicenter study. Japanese Pharmacology and Therapeutics1985;12(12):119‐37. ">Fujimaki 1985</a>; <a href="./references#CD007402-bbs2-0057" title="SugiokaY . Multicenter clinical evaluation of piroxicam gel vs. indomethacin gel in the treatment of non‐traumatic diseases of tendon or muscle. Japanese Pharmacology and Therapeutics1984;12:139‐53. ">Sugioka 1984</a>), ibuprofen versus ketoprofen (<a href="./references#CD007402-bbs2-0010" title="CurioniBG , DiDomenicaF , DaolioP , SpignoliG . Evaluation of ibuproxam gel in traumatology [Valutazione dell'efficacia terapeutica di ibudros gel in traumatologia]. Clinica Europea1985;24(3):456‐60. ">Curioni 1985</a>; <a href="./references#CD007402-bbs2-0045" title="PicchioAA , VoltaS , LongoniA . Controlled clinical trial of ibuprofen for topical use in sport injuries [Studio clinico controllato sull'impiego dell'ibuprofen per uso topico in traumatologica sportiva]. Medicina dello Sport1981;34:403‐6. ">Picchio 1981</a>), ketoprofen versus etofenamate (<a href="./references#CD007402-bbs2-0010" title="CurioniBG , DiDomenicaF , DaolioP , SpignoliG . Evaluation of ibuproxam gel in traumatology [Valutazione dell'efficacia terapeutica di ibudros gel in traumatologia]. Clinica Europea1985;24(3):456‐60. ">Curioni 1985</a>; <a href="./references#CD007402-bbs2-0059" title="TonuttiA . The use of ketoprofen gel 5% (orudis gel) in traumatology: controlled double‐blind study vs etofenamate [Utilizzazione del ketoprofene gel 5% (orudis gel) nella pratica traumatologica: studio in doppio cieco controllato verso etofenamato]. Ortopedia e Traumatologia Oggi1994;14(3):119‐25. ">Tonutti 1994</a>), ibuprofen versus etofenamate (<a href="./references#CD007402-bbs2-0010" title="CurioniBG , DiDomenicaF , DaolioP , SpignoliG . Evaluation of ibuproxam gel in traumatology [Valutazione dell'efficacia terapeutica di ibudros gel in traumatologia]. Clinica Europea1985;24(3):456‐60. ">Curioni 1985</a>), ketorolac versus etofenamate (<a href="./references#CD007402-bbs2-0011" title="DiebschlagW , NockerW , BullinghamR . A double‐blind study of the efficacy of topical ketorolac tromethamine gel in the treatment of ankle sprain, in comparison to placebo and etofenamate. Journal of Clinical Pharmacology1990;30(1):82‐9. ">Diebshlag 1990</a>), and diclofenac versus lysine clonixinate (<a href="./references#CD007402-bbs2-0024" title="HofmanJ , NasswetterG , CayettiLM . Lysine clonixinate gel in soft tissue injuries. Controlled randomized prospective double‐blind clinical trial with diclofenac [Clonixinato de lisina gel en lesiones de tejidos blandos ensayo clinico prospectivo doble ciego al azar controlado con diclofenac]. Prensa Medica Argentina2000;87(5):513‐20. ">Hofman 2000</a>). </p> <p>There were sufficient data to compare only piroxicam with indomethacin (<a href="./references#CD007402-bbs2-0003" title="AokiT , NumajiriM , YamamotoM . A well controlled comparative study of piroxicam gel, indomethacin gel and placebo gel in the treatment of trauma. Japanese Pharmacology and Therapeutics1984;12(12):101‐17. ">Aoki 1984</a>; <a href="./references#CD007402-bbs2-0017" title="FujimakiE , et al. Clinical evaluation of piroxicam gel versus indomethacin gel and placebo in the treatment of muscle pain: a double‐blind, multicenter study. Japanese Pharmacology and Therapeutics1985;12(12):119‐37. ">Fujimaki 1985</a>; <a href="./references#CD007402-bbs2-0057" title="SugiokaY . Multicenter clinical evaluation of piroxicam gel vs. indomethacin gel in the treatment of non‐traumatic diseases of tendon or muscle. Japanese Pharmacology and Therapeutics1984;12:139‐53. ">Sugioka 1984</a>; <a href="./references#CD007402-fig-0015" title="">Analysis 6.1</a>). </p> <p> <ul id="CD007402-list-0019"> <li> <p>The proportion of participants experiencing clinical success with topical piroxicam was 56% (185/330, range 49% to 78%). </p> </li> <li> <p>The proportion of participants experiencing clinical success with topical indomethacin was 45% (140/311, range 33% to 64%). </p> </li> <li> <p>The RR of piroxicam compared with indomethacin was 1.2 (1.1 to 1.4).</p> </li> <li> <p>The NNT for successful treatment was 9.1 (5.3 to 30). For every nine participants treated with topical piroxicam, one would experience a clinical success who would not have experienced one with topical indomethacin. </p> </li> </ul> </p> </section> <section id="CD007402-sec-0087"> <h5 class="title">Topical NSAID versus different topical intervention</h5> <p>One study compared diclofenac gel with a herbal product called Traumeel gel under double‐blind conditions, with response rates for being pain‐free at seven days of 8/137 (5.8%) with diclofenac gel and 7/140 (5.0%) with Traumeel gel (<a href="./references#CD007402-bbs2-0019" title="González de VegaC , SpeedC , WolfarthB , GonzálezJ . Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: a multicentre, randomised, blinded, controlled and non‐inferiority trial. International Journal of Clinical Practice2013;67(10):979‐89. [DOI: 10.1111/ijcp.12219] ">González de Vega 2013</a>). </p> </section> </section> <section id="CD007402-sec-0088"> <h4 class="title">Local adverse events</h4> <section id="CD007402-sec-0089"> <h5 class="title">Topical NSAID versus oral NSAID</h5> <p>Two studies comparing a topical NSAID with an oral NSAID provided data on local adverse events (<a href="./references#CD007402-bbs2-0002" title="ĂkermarkC , ForsskåhlB . Topical indomethacin in overuse injuries in athletes. A randomized double blind study comparing Elmetacin® with oral indomethacin and placebo. International Journal of Sports Medicine1990;11(5):393‐6. ">Ăkermark 1990</a>; <a href="./references#CD007402-bbs2-0025" title="HosieGAC . The topical NSAID, felbinac, versus oral ibuprofen: a comparison of efficacy in the treatment of acute lower back injury. British Journal of Clinical Research1993;4:5‐17. ">Hosie 1993</a>). There were five events with topical NSAID and three with oral NSAID, which were too few for analysis. </p> </section> <section id="CD007402-sec-0090"> <h5 class="title">Topical NSAID versus different topical NSAID</h5> <p>All nine studies comparing one topical NSAID with at least one other reported on local adverse events, with a total of 48 events in 1005 participants (4.8%). There were sufficient data to compare only piroxicam with indomethacin (<a href="./references#CD007402-bbs2-0003" title="AokiT , NumajiriM , YamamotoM . A well controlled comparative study of piroxicam gel, indomethacin gel and placebo gel in the treatment of trauma. Japanese Pharmacology and Therapeutics1984;12(12):101‐17. ">Aoki 1984</a>; <a href="./references#CD007402-bbs2-0017" title="FujimakiE , et al. Clinical evaluation of piroxicam gel versus indomethacin gel and placebo in the treatment of muscle pain: a double‐blind, multicenter study. Japanese Pharmacology and Therapeutics1985;12(12):119‐37. ">Fujimaki 1985</a>; <a href="./references#CD007402-bbs2-0057" title="SugiokaY . Multicenter clinical evaluation of piroxicam gel vs. indomethacin gel in the treatment of non‐traumatic diseases of tendon or muscle. Japanese Pharmacology and Therapeutics1984;12:139‐53. ">Sugioka 1984</a>; <a href="./references#CD007402-fig-0016" title="">Analysis 6.2</a>). </p> <p> <ul id="CD007402-list-0020"> <li> <p>The proportion of participants experiencing local adverse events with topical piroxicam was 2.1% (7/340, range 1.2% to 2.8%). </p> </li> <li> <p>The proportion of participants experiencing local adverse events with topical indomethacin was 10% (33/331, range 2.9% to 15%). </p> </li> <li> <p>The RR of piroxicam compared with indomethacin was 0.21 (0.09 to 0.47).</p> </li> <li> <p>The NNT to prevent a local adverse event was 13 (8.7 to 23). For every thirteen participants treated with topical piroxicam, one would not experience a local adverse event who would have experienced one with topical indomethacin. </p> </li> </ul> </p> </section> <section id="CD007402-sec-0091"> <h5 class="title">Topical NSAID versus different topical intervention</h5> <p><a href="./references#CD007402-bbs2-0019" title="González de VegaC , SpeedC , WolfarthB , GonzálezJ . Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: a multicentre, randomised, blinded, controlled and non‐inferiority trial. International Journal of Clinical Practice2013;67(10):979‐89. [DOI: 10.1111/ijcp.12219] ">González de Vega 2013</a> reported that adverse events were infrequent and mild to moderate in intensity, but did not distinguish between local and systemic events. Numbers of participants experiencing any adverse event were 8/147 with diclofenac gel and 14/148 with Traumeel gel. </p> </section> </section> <section id="CD007402-sec-0092"> <h4 class="title">Systemic adverse events</h4> <p><a href="./references#CD007402-bbs2-0002" title="ĂkermarkC , ForsskåhlB . Topical indomethacin in overuse injuries in athletes. A randomized double blind study comparing Elmetacin® with oral indomethacin and placebo. International Journal of Sports Medicine1990;11(5):393‐6. ">Ăkermark 1990</a> reported numbers of events, rather than numbers of participants with events, while <a href="./references#CD007402-bbs2-0059" title="TonuttiA . The use of ketoprofen gel 5% (orudis gel) in traumatology: controlled double‐blind study vs etofenamate [Utilizzazione del ketoprofene gel 5% (orudis gel) nella pratica traumatologica: studio in doppio cieco controllato verso etofenamato]. Ortopedia e Traumatologia Oggi1994;14(3):119‐25. ">Tonutti 1994</a> and <a href="./references#CD007402-bbs2-0061" title="WhitefieldM , O'KaneCJA , AndersonS . Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomised, double blind study. Journal of Clinical Pharmacy and Therapeutics2002;27(6):409‐17. ">Whitefield 2002</a> reported no adverse events attributable to the study medication, and <a href="./references#CD007402-bbs2-0016" title="FioravantiA , CiceroMR , NerucciF , ManopuloR , MarcolongoR . Double‐blind controlled clinical study of the efficacy and tolerability of diclofenac‐N‐(2‐hydroxyethyl)‐pyrrolidine lecithin gel compared with diclofenac‐N‐(2‐hydroxyethyl)‐pyrrolidine gel in patients with peri and extraarticular inflammatory diseases. Drugs under Experimental and Clinical Research1999;25(5):235‐40. ">Fioravanti 1999</a>, <a href="./references#CD007402-bbs2-0018" title="GallacchiG , MautoneG , LauldiP . Topical treatment with diclofenac hydroxyethylpyrrilidine (Flector gel 1%). Clinical Trials Journal1990;27(1):58‐64. ">Gallacchi 1990</a>, <a href="./references#CD007402-bbs2-0021" title="GualdiA , BonolloL , MartiniA , ForgioneA . Non‐steroidal anti‐inflammatory drugs for topical therapy in traumatology: a double‐blind study with flunoxaprofen and ketoprofen [Antinflammatori no steroidi per uso topico in traumatologia: studio clinico con flunoxaprofene e chetoprofene]. Riforma Medica1987;102(10):401‐4. ">Gualdi 1987,</a> and <a href="./references#CD007402-bbs2-0057" title="SugiokaY . Multicenter clinical evaluation of piroxicam gel vs. indomethacin gel in the treatment of non‐traumatic diseases of tendon or muscle. Japanese Pharmacology and Therapeutics1984;12:139‐53. ">Sugioka 1984</a> did not mention systemic adverse events. <a href="./references#CD007402-bbs2-0019" title="González de VegaC , SpeedC , WolfarthB , GonzálezJ . Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: a multicentre, randomised, blinded, controlled and non‐inferiority trial. International Journal of Clinical Practice2013;67(10):979‐89. [DOI: 10.1111/ijcp.12219] ">González de Vega 2013</a> did not distinguish between local and systemic events. In the remaining studies a total of 16 events were reported in topical NSAID treatment arms (797 participants, 2%) and 11 with ibuprofen tablets (134 participants, 8%). </p> </section> <section id="CD007402-sec-0093"> <h4 class="title">Serious adverse events</h4> <p>No serious adverse events were reported in any treatment arm.</p> </section> <section id="CD007402-sec-0094"> <h4 class="title">Withdrawals</h4> <p>The only withdrawals reported due to adverse events were in studies with placebo treatment arms (<a href="./references#CD007402-bbs2-0002" title="ĂkermarkC , ForsskåhlB . Topical indomethacin in overuse injuries in athletes. A randomized double blind study comparing Elmetacin® with oral indomethacin and placebo. International Journal of Sports Medicine1990;11(5):393‐6. ">Ăkermark 1990</a>; <a href="./references#CD007402-bbs2-0017" title="FujimakiE , et al. Clinical evaluation of piroxicam gel versus indomethacin gel and placebo in the treatment of muscle pain: a double‐blind, multicenter study. Japanese Pharmacology and Therapeutics1985;12(12):119‐37. ">Fujimaki 1985</a>), and have been reviewed. </p> <p>Three studies reported withdrawals due to lack of efficacy (<a href="./references#CD007402-bbs2-0019" title="González de VegaC , SpeedC , WolfarthB , GonzálezJ . Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: a multicentre, randomised, blinded, controlled and non‐inferiority trial. International Journal of Clinical Practice2013;67(10):979‐89. [DOI: 10.1111/ijcp.12219] ">González de Vega 2013</a>; <a href="./references#CD007402-bbs2-0024" title="HofmanJ , NasswetterG , CayettiLM . Lysine clonixinate gel in soft tissue injuries. Controlled randomized prospective double‐blind clinical trial with diclofenac [Clonixinato de lisina gel en lesiones de tejidos blandos ensayo clinico prospectivo doble ciego al azar controlado con diclofenac]. Prensa Medica Argentina2000;87(5):513‐20. ">Hofman 2000</a>; <a href="./references#CD007402-bbs2-0059" title="TonuttiA . The use of ketoprofen gel 5% (orudis gel) in traumatology: controlled double‐blind study vs etofenamate [Utilizzazione del ketoprofene gel 5% (orudis gel) nella pratica traumatologica: studio in doppio cieco controllato verso etofenamato]. Ortopedia e Traumatologia Oggi1994;14(3):119‐25. ">Tonutti 1994</a>) (<a href="./appendices#CD007402-sec-0119">Appendix 5</a>). There were insufficient data for analysis. </p> <p>Some studies reported exclusions from analysis (efficacy or safety, or both) following randomisation, mainly due to protocol violations or loss to follow‐up (<a href="./appendices#CD007402-sec-0119">Appendix 5</a>). There is no reason to believe these exclusions would introduce systematic bias, and the numbers involved were not likely to influence results. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007402-sec-0095" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007402-sec-0095"></div> <p>This updated review of topical NSAIDs for acute musculoskeletal pain in adults differs from previous reviews. Previously, data allowed only for comparison of individual topical NSAIDs with placebo, irrespective of formulation. With a substantial amount of new data for diclofenac, it is possible to distinguish effects of formulation for individual NSAIDs. Because formulation chemistry can substantially affect the rate and total amount of drug accessing subcutaneous injured tissues, the effect of formulation may be as important as the individual NSAID used. Drug and formulation should thus be considered together when assessing efficacy, and this is now possible. </p> <p>We have also included an assessment of the daily dose of NSAID applied to the skin. This involved having information on the concentration of NSAID in the preparation, the amount used, and the frequency of use. Not all studies reported all three, but an estimation of topical doses applied was possible. It varied by factors of three or four for each topical NSAID. However, for topical formulations, the key issue is less the dose applied but the amount that penetrates locally (producing analgesic effect) and the amount entering the systemic circulation (producing potential harms). Both will depend on the exact formulation of the topical agent, and whether there is occlusion (<a href="./references#CD007402-bbs2-0134" title="MooreRA , DerryS , McQuayHJ . Topical agents in the treatment of rheumatic pain. Rheumatic Diseases Clinics of North America2008;34(2):415‐32. ">Moore 2008a</a>). </p> <section id="CD007402-sec-0096"> <h3 class="title" id="CD007402-sec-0096">Summary of main results</h3> <p>This review included 61 studies comparing a topical NSAID with placebo, another topical NSAID, or an oral NSAID. In total, 5311 participants were treated with a topical NSAID, 3470 with placebo, and 220 with an oral NSAID. There were 63% more participants than in the previous version of this review. Conditions treated were sprains, strains, and contusions, mainly resulting from sports injuries, and overuse injuries such as tendinitis. </p> <p>Formulations of topical diclofenac, ibuprofen, ketoprofen, piroxicam, and indomethacin demonstrated significantly higher rates of clinical success than matching topical placebo lacking the NSAID; benzydamine did not. Three drug and formulation combinations had NNTs for clinical success below 4. For diclofenac, Emulgel® had the lowest NNT of 1.8 (1.5 to 2.1) in two studies using at least 50% pain intensity reduction as the outcome (high quality evidence). Diclofenac plasters other than Flector® also had a low NNT of 3.2 (2.6 to 4.2) based on good or excellent responses in relatively recent studies (high quality evidence). Ketoprofen gel had an NNT of 2.5 (2.0 to 3.4) from five studies in the 1980s, some with less well defined outcomes (moderate quality evidence). Ibuprofen gel had an NNT of 3.9 (2.7 to 6.7) from two studies with outcomes of marked improvement or complete remission (moderate quality evidence). All other drug and formulation combinations had NNT values above 4, indicating lesser efficacy. </p> <p>These results are better than alternative topical products that might be used for acute musculoskeletal pain. There is no evidence to support the use of topical salicylate rubefacients (<a href="./references#CD007402-bbs2-0116" title="DerryS , MatthewsPR , WiffenPJ , MooreRA . Salicylate‐containing rubefacients for acute and chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews2014, Issue 11. [DOI: 10.1002/14651858.CD007403.pub3] ">Derry 2014</a>). </p> <p>Treatment with a topical NSAID was not associated with an increase in local adverse events (skin reactions) compared with placebo (inert carrier), or in withdrawals due to adverse events (high quality evidence). The inert carrier was sometimes associated with mild skin irritation, but this rarely led to cessation of treatment, and quickly resolved. Systemic adverse events were uncommon and did not differ between topical NSAID and placebo (high quality evidence). Two participants experienced serious adverse events with diclofenac plaster and diclofenac gel, but it is unlikely that these were related to the study medications. </p> <p>There were insufficient data directly comparing a topical NSAID with the same oral NSAID to draw conclusions about efficacy. Based on very limited data for oral NSAIDs, there were fewer systemic adverse events with topical than oral treatment. There were sufficient data only for topical piroxicam compared with topical indomethacin to compare one topical agent with another. These limited data suggested that piroxicam was more effective than indomethacin, and was less likely to cause local adverse events. It is worth noting here that topical indomethacin did not give significantly better pain relief than placebo in two of the three studies in this analysis. </p> </section> <section id="CD007402-sec-0097"> <h3 class="title" id="CD007402-sec-0097">Overall completeness and applicability of evidence</h3> <p>There is a tension between pooling studies to produce analyses with larger numbers and the subsequent large increases in clinical and statistical heterogeneity on the one hand, and using the approach of clinical homogeneity with subsequent smaller numbers of participants on the other hand. Previous reviews have taken the former approach; that is useful in demonstrating that topical NSAIDs 'work' by being significantly better than placebo. Because of the substantial increase in the amount of data available, in this review we have chosen to seek greater clinical homogeneity; this produces results that are more relevant to patient and prescriber choice. </p> <p>There were too few studies comparing one topical NSAID versus another, or versus the same oral NSAID, to allow meaningful direct comparisons between individual drugs or routes of administration. </p> <p>The conditions treated in these studies are representative of those likely to be suitable for acute treatment with topical NSAIDs. The mean age of participants in individual studies ranged from 25 to 57 years, and the nature of recruitment in many studies meant that participants were actively engaged in sporting activities. Nevertheless, older people in their 60s to 80s were also included in some studies, and the low levels of predominantly mild adverse events means that this route of administration of NSAIDs is suitable for all age groups able to manage the application process. </p> <p>Information from other sources, mainly randomised studies lasting 12 weeks or more in older populations with arthritis, tend to confirm this. A systematic review of topical NSAIDs in older adults was difficult to interpret, but suggested that the range of withdrawal rates in these studies was similar with topical and oral NSAIDs (<a href="./references#CD007402-bbs2-0125" title="MakrisUE , KohlerMJ , FraenkelL . Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review. Journal of Rheumatology2010;37(6):1236‐43. [DOI: 10.3899/jrheum.090935] ">Makris 2010</a>). It also claimed potentiation of warfarin effects, but that was with topical salicylate, not an NSAID. In contrast, a pooled safety analysis of topical diclofenac in people aged 75 years or older reported minimal changes, with a mean reduction in haemoglobin of less than 1 g/L with topical diclofenac, and a mean systolic blood pressure reduction of almost 4 mm Hg (<a href="./references#CD007402-bbs2-0143" title="RothSH , FullerP . Pooled safety analysis of diclofenac sodium topical solution 1.5% (w/w) in the treatment of osteoarthritis in patients aged 75 years or older. Clinical Interventions in Aging2012;7:127‐37. [DOI: 10.2147/CIA.S30884] ">Roth 2012</a>). Two large randomised 12‐week studies comparing topical with oral diclofenac in arthritis reported lower rates of gastrointestinal adverse events with topical than oral, especially severe events, but larger reductions in haemoglobin with oral diclofenac (<a href="./references#CD007402-bbs2-0144" title="SimonLS , GriersonLM , NaseerZ , BookmanAA , Zev ShainhouseJ . Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain2009;143(3):238‐45. [DOI: 10.1016/j.pain.2009.03.008] ">Simon 2009</a>; <a href="./references#CD007402-bbs2-0146" title="TugwellPS , WellsGA , ShainhouseJZ . Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. Journal of Rheumatology2004;31(10):2002‐12. ">Tugwell 2004</a>). </p> <p>The available evidence was limited by numbers to comment on rare but potentially serious adverse events. One example is the potential for photo‐sensitivity reactions with topical ketoprofen. Current advice from the Medicines and Healthcare products Regulatory Agency in the UK is to avoid direct sunlight, ultraviolet (UV) rays, sunlamps, and sunbeds while using topical ketoprofen, and to see a healthcare professional or go to hospital if they experience a skin reaction to sunlight, sunlamps, or sunbeds (<a href="./references#CD007402-bbs2-0129" title="Medicines and Healthcare Products Regulatory Agency. Topical ketoprofen: reminder on risk of photo‐sensitivity reactions. Drug Safety Update2009 June; Vol. 2, issue 11:6. ">MHRA 2009</a>). </p> </section> <section id="CD007402-sec-0098"> <h3 class="title" id="CD007402-sec-0098">Quality of the evidence</h3> <p>All included studies were both randomised and double‐blind; none was considered at high risk of methodological bias. Many were carried out in the 1980s and 1990s when methodological rigor and detailed reporting were not given such high priority and studies did not always report details of the randomisation, treatment allocation, and blinding processes. More recent studies often did report methodological details, and tended to be larger (see <a href="#CD007402-fig-0004">Figure 4</a> for a comparison of quality of reporting for different dates and NSAIDs). Our primary outcome of clinical success was not always well‐defined, and was measured using different scales, but again more recent studies tended to report outcomes better. </p> <p>The studies were conducted in different conditions, with somewhat different outcome definitions and duration, and with different topical NSAIDs and formulations. Moreover, the small size of many of the studies is likely to result in considerable chance variation (<a href="./references#CD007402-bbs2-0111" title="CounsellCE , ClarkeMJ , SlatteryJ , SandercockPA . The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis?. BMJ1994;309(6970):1677‐81. ">Counsell 1994</a>; <a href="./references#CD007402-bbs2-0131" title="MooreRA , GavaghanD , TramèrMR , CollinsSL , McQuayHJ . Size is everything ‐ large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain1998;78(3):209‐16. ">Moore 1998b</a>). These factors would account for the high I<sup>2</sup> values seen in several analyses. Despite these sources of potential clinical heterogeneity, most studies showed benefit of topical NSAID over placebo. </p> <p>The design of studies to be able to demonstrate analgesic sensitivity is important in self limiting conditions such as strains and sprains. Too long a duration and the condition results in spontaneous resolution of painful symptoms, while too short a duration may be inadequate to show any effect. The decision by trialists to concentrate on outcomes closest to seven days of treatment appears to be prudent, and has been adopted in this and previous reviews. There are potential differences in response to treatment between strains and sprains and overuse‐type injuries such as tendinitis, and future reviews may examine this. At the present time, there are too few existing trials to explore any differences adequately. </p> <p>Baseline pain may be a cause for concern. Seven studies did not report baseline pain levels (<a href="./references#CD007402-bbs2-0005" title="BilligmannPW . Treatment of ankle distortion with ibuprofen gel [Therapie von Sprunggelenks‐distosionen mit ibuprofen‐mikrogel]. Therapiewoche1996;46(21):1187‐92. ">Billigmann 1996</a>; <a href="./references#CD007402-bbs2-0010" title="CurioniBG , DiDomenicaF , DaolioP , SpignoliG . Evaluation of ibuproxam gel in traumatology [Valutazione dell'efficacia terapeutica di ibudros gel in traumatologia]. Clinica Europea1985;24(3):456‐60. ">Curioni 1985</a>; <a href="./references#CD007402-bbs2-0022" title="HaigG . Portable thermogram technique for topically applied benzydamine cream in acute soft‐tissue injuries. Internation Journal of Tissue Reactions1986;8(2):145‐7. ">Haig 1986</a>; <a href="./references#CD007402-bbs2-0040" title="Novartis(Sponsors) . A randomized, double‐blind, multi‐center, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied 4 times daily in subjects with acute ankle sprain. clinicaltrials.gov/ct2/show/NCT01255423 (accessed 3 February 2015)2012. [CTG: NCT01255423] ">NCT01255423</a>; <a href="./references#CD007402-bbs2-0041" title="Novartis(Sponsors) . A randomized, double‐blind, multi‐center, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied four times daily in subjects with acute ankle sprain. clinicaltrials.gov/ct2/show/results/NCT01272934 (accessed 3 February 2015)2013. [CTG: NCT01272934] ">NCT01272934</a>; <a href="./references#CD007402-bbs2-0042" title="Novartis(Sponsors) . A randomized, double‐blind, multi‐center, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied four times daily in subjects with acute blunt soft tissue injuries/contusions of the limbs. clinicaltrials.gov/ct2/show/results/NCT01272947 (accessed 3 February 2015)2012. [CTG: NCT01272947] PallayR , PabstH , GiannettiB , BurnettI , MonnetJ . Diclofenac sodium topical gel (DSG) 1% for acute soft tissue injuries/contusions of the limbs. 2013 Annual Assembly of the American Academy of Physical Medicine and Rehabilitation. National Harbor, MD United States, 2013; Vol. 5 (9 Suppl 1):S204. ">NCT01272947</a>; <a href="./references#CD007402-bbs2-0055" title="SinnigerM , BlanchardP . Controlled clinical trial with Fentiazac cream in sport microtraumatology. Journal of International Medical Research1981;9(4):300‐2. ">Sinniger 1981</a>), and a further 11 reported either mean levels of less than moderate pain or a significant proportion of individuals with less than moderate pain (<a href="./references#CD007402-bbs2-0002" title="ĂkermarkC , ForsskåhlB . Topical indomethacin in overuse injuries in athletes. A randomized double blind study comparing Elmetacin® with oral indomethacin and placebo. International Journal of Sports Medicine1990;11(5):393‐6. ">Ăkermark 1990</a>; <a href="./references#CD007402-bbs2-0003" title="AokiT , NumajiriM , YamamotoM . A well controlled comparative study of piroxicam gel, indomethacin gel and placebo gel in the treatment of trauma. Japanese Pharmacology and Therapeutics1984;12(12):101‐17. ">Aoki 1984</a>; <a href="./references#CD007402-bbs2-0004" title="AuclairJ , GeorgesM , GraptonX , GrypL , D'HoogheM , MeisserRG , et al. A double‐blind controlled multi‐center study of percutaneous niflumic acid gel and placebo in the treatment of Achilles heel tendinitis. Current Therapeutic Research1989;46(4):782‐8. ">Auclair 1989</a>; <a href="./references#CD007402-bbs2-0011" title="DiebschlagW , NockerW , BullinghamR . A double‐blind study of the efficacy of topical ketorolac tromethamine gel in the treatment of ankle sprain, in comparison to placebo and etofenamate. Journal of Clinical Pharmacology1990;30(1):82‐9. ">Diebshlag 1990</a>; <a href="./references#CD007402-bbs2-0017" title="FujimakiE , et al. Clinical evaluation of piroxicam gel versus indomethacin gel and placebo in the treatment of muscle pain: a double‐blind, multicenter study. Japanese Pharmacology and Therapeutics1985;12(12):119‐37. ">Fujimaki 1985</a>; <a href="./references#CD007402-bbs2-0026" title="JenourePJ , RostanA , GremionG , MeierJL , GrossenR , BielinkiR , et al. Multicentre, double‐blind, controlled clinical study on the efficacy of diclofenac epolamine Tissugel plaster in patients with epicondylitis [Studio multicentrico controllato in doppio cieco su diclofenac Tissugel plaster in pazienti con epicondilite]. Medicina Dello Sport1977;50(3):285‐92. ">Jenoure 1997</a>; <a href="./references#CD007402-bbs2-0033" title="LindeF , HvassI , JürgensenU , MadsenF . Treatment of sprained ankles with 5% benzydamine creme. A double‐blind study [Ankelforstuvninger behandlet med benzydamin 5% creme]. Ugeskrift for Laeger1985;148(1):12‐3. ">Linde 1985</a>; <a href="./references#CD007402-bbs2-0045" title="PicchioAA , VoltaS , LongoniA . Controlled clinical trial of ibuprofen for topical use in sport injuries [Studio clinico controllato sull'impiego dell'ibuprofen per uso topico in traumatologica sportiva]. Medicina dello Sport1981;34:403‐6. ">Picchio 1981</a>; <a href="./references#CD007402-bbs2-0050" title="RameshN , SteuberU . Ibuprofen in a cream vehicle for accidental and sport injuries [Dolgit creme bei unfall‐ und sportverletzungen]. Therapiewoche1983;33:4563‐70. ">Ramesh 1983</a>; <a href="./references#CD007402-bbs2-0057" title="SugiokaY . Multicenter clinical evaluation of piroxicam gel vs. indomethacin gel in the treatment of non‐traumatic diseases of tendon or muscle. Japanese Pharmacology and Therapeutics1984;12:139‐53. ">Sugioka 1984</a>; <a href="./references#CD007402-bbs2-0061" title="WhitefieldM , O'KaneCJA , AndersonS . Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomised, double blind study. Journal of Clinical Pharmacy and Therapeutics2002;27(6):409‐17. ">Whitefield 2002</a>), using recognised scales. Insufficient pain at baseline compromises the ability of a study to demonstrate any improvement. All the newly added studies reported baseline pain to be of at least moderate intensity. </p> </section> <section id="CD007402-sec-0099"> <h3 class="title" id="CD007402-sec-0099">Potential biases in the review process</h3> <p>There has been greater interest in topical NSAIDs in recent years, mainly because lower systemic drug levels reduce the risk of troublesome and severe adverse events, particularly in the gastrointestinal tract, and renal and cardiovascular systems. Most of the attention has been in chronic conditions such as osteoarthritis, with few studies in acute painful conditions. Low levels of serious adverse events with topical NSAIDs has been noted previously (<a href="./references#CD007402-bbs2-0117" title="EvansJM , McMahonAD , McGilchristMM , WhiteG , MurrayFE , McDevittDG , et al. Topical non‐steroidal anti‐inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case‐control study. BMJ1995;311(6996):22‐6. ">Evans 1995</a>), and the near absence of serious adverse events in this review is unlikely to be due to any biases in the review process. </p> <p>One potential bias is that clinical trials for topical NSAIDs may not have been published. One previous review did find previously unpublished trials (<a href="./references#CD007402-bbs2-0130" title="MooreRA , TramèrMR , CarrollD , WiffenPJ , McQuayHJ . Quantitative systematic review of topically applied non‐steroidal anti‐inflammatory drugs. BMJ1998;316(7128):333‐8. ">Moore 1998a</a>), but a subsequent attempt that included extensive contacts with pharmaceutical companies revealed no additional data (<a href="./references#CD007402-bbs2-0126" title="MasonL , MooreRA , EdwardsJE , DerryS , McQuayHJ . Topical NSAIDs for acute pain: a meta‐analysis. BMC Family Practice2004;5:10. ">Mason 2004a</a>). While some old unpublished studies of topical NSAIDs in acute painful conditions may exist, they constitute an unknown number of studies and participants whose results are unknown, and are likely to remain unknown. Furthermore, their relevance to current clinical practice may be limited as better formulations are developed. New systems of trial registration mean that we know what recent studies have been done or are ongoing; the number of studies and participants is known even if their results remain unknown. We identified in Clinicaltrials.gov three unpublished studies (612 participants) with adverse event data but no dichotomous efficacy data, 14 completed unpublished studies (4403 participants) with no results posted, and three ongoing studies (880 participants). </p> <p>For the main topical NSAIDs of interest and where most information exists, about 4200 participants in this review provided data on efficacy for diclofenac, ibuprofen, ketoprofen, indomethacin, and benzydamine compared with placebo. For efficacy, there are unknown results from almost 5900 participants in studies known to have been done but essentially unpublished. Almost 6500 participants in this review provided information on local adverse events for topical NSAIDs compared with placebo. For local adverse events, the unknown results from known studies represents almost 5300 participants. It is clear that identified unpublished but unavailable study data amounts to a further potentially large increase in knowledge, over and above the 60% increase in numbers of participants already included in this updated review. </p> <p>Based on efficacy data on known and available study results, unpublished trials showing no difference between any topical NSAID and topical placebo and involving 5500 participants would have to exist in order for the NNT to be as high as 9, at which point the effectiveness of topical NSAIDs would become clinically irrelevant (<a href="./references#CD007402-bbs2-0133" title="MooreRA , BardenJ , DerryS , McQuayHJ . Managing potential publication bias. In: McQuayHJ , KalsoE , MooreRA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2006:15‐23. [ISBN: 978‐0‐931092‐69‐5] ">Moore 2006</a>). This amount of unpublished negative data is obviously available, and while a negative result in all the identified studies is unlikely, knowledge would be greatly served by having these unpublished trial results available. </p> <p>We have not yet attempted to obtain results from these clinical trials from the trial sponsors, because this takes a considerable amount of time and may not be successful. Moreover, the studies were spilt between nine different sponsors: Cerimon Pharmaceuticals (five studies), Novartis (four studies), Endo Pharmaceuticals (three studies), GlaxoSmithKline (two studies), Hisamatsu Pharmaceutical (two studies), and one each from Actavis, Pfizer, Imprimis Pharmaceutical, and Strategic Science &amp; Technologies. </p> </section> <section id="CD007402-sec-0100"> <h3 class="title" id="CD007402-sec-0100">Agreements and disagreements with other studies or reviews</h3> <p>A review published in 2004 included some of the studies in this review and reported an NNT for all topical NSAIDs combined of 3.8 (3.4 to 4.4) for clinical success equivalent to half pain relief at seven days (<a href="./references#CD007402-bbs2-0126" title="MasonL , MooreRA , EdwardsJE , DerryS , McQuayHJ . Topical NSAIDs for acute pain: a meta‐analysis. BMC Family Practice2004;5:10. ">Mason 2004a</a>). That review found no difference between topical NSAID and placebo for local adverse events, as did this review. In turn, the Mason review was in broad agreement with the original systematic review on topical NSAIDs (<a href="./references#CD007402-bbs2-0130" title="MooreRA , TramèrMR , CarrollD , WiffenPJ , McQuayHJ . Quantitative systematic review of topically applied non‐steroidal anti‐inflammatory drugs. BMJ1998;316(7128):333‐8. ">Moore 1998a</a>). To our knowledge, no previous review assembled sufficient trial data to analyse results by both drug and formulation, as was done here. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007402-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD007402-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007402-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD007402-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Individual NSAID versus placebo, outcome: 2.1 Clinical success." data-id="CD007402-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Individual NSAID versus placebo, outcome: 2.1 Clinical success. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="L'Abbé plot of clinical success in studies of topical diclofenac versus topical placebo. The size of the symbol is proportional to the size of the study (inset scale). Dark blue: Emulgel; light blue: spray/gel; red: Flector; pink: other patch or plaster." data-id="CD007402-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>L'Abbé plot of clinical success in studies of topical diclofenac versus topical placebo. The size of the symbol is proportional to the size of the study (inset scale). Dark blue: Emulgel; light blue: spray/gel; red: Flector; pink: other patch or plaster. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="L'Abbé plot of clinical success in studies of topical ketoprofen versus topical placebo. The size of the symbol is proportional to the size of the study (inset scale). Light blue: ketoprofen gel; pink: ketoprofen plaster." data-id="CD007402-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>L'Abbé plot of clinical success in studies of topical ketoprofen versus topical placebo. The size of the symbol is proportional to the size of the study (inset scale). Light blue: ketoprofen gel; pink: ketoprofen plaster. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Individual NSAID versus placebo, Outcome 1 Clinical success." data-id="CD007402-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Individual NSAID versus placebo, Outcome 1 Clinical success.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Individual NSAID versus placebo, Outcome 2 Local adverse events." data-id="CD007402-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Individual NSAID versus placebo, Outcome 2 Local adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Diclofenac versus placebo (effect of formulation), Outcome 1 Clinical success." data-id="CD007402-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Diclofenac versus placebo (effect of formulation), Outcome 1 Clinical success. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Ibuprofen versus placebo (effect of formulation), Outcome 1 Clinical success." data-id="CD007402-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Ibuprofen versus placebo (effect of formulation), Outcome 1 Clinical success. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ketoprofen versus placebo, Outcome 1 Clinical success." data-id="CD007402-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Ketoprofen versus placebo, Outcome 1 Clinical success.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 All topical NSAIDs versus placebo, Outcome 1 Local adverse events." data-id="CD007402-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 All topical NSAIDs versus placebo, Outcome 1 Local adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 All topical NSAIDs versus placebo, Outcome 2 Systemic adverse events." data-id="CD007402-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 All topical NSAIDs versus placebo, Outcome 2 Systemic adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 All topical NSAIDs versus placebo, Outcome 3 Adverse event withdrawals." data-id="CD007402-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 All topical NSAIDs versus placebo, Outcome 3 Adverse event withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Topical NSAID versus active comparator, Outcome 1 Clinical success ‐ topical piroxicam vs topical indomethacin." data-id="CD007402-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Topical NSAID versus active comparator, Outcome 1 Clinical success ‐ topical piroxicam vs topical indomethacin. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007402-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/urn:x-wiley:14651858:media:CD007402:CD007402-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_t/tCD007402-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Topical NSAID versus active comparator, Outcome 2 Local adverse events ‐ topical piroxicam vs topical indomethacin." data-id="CD007402-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Topical NSAID versus active comparator, Outcome 2 Local adverse events ‐ topical piroxicam vs topical indomethacin. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/media/CDSR/CD007402/image_n/nCD007402-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007402-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Topical NSAIDs compared with topical placebo for acute musculoskeletal pain in adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Topical NSAIDs compared with topical placebo for acute musculoskeletal pain in adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with strains, sprains, or muscle pull </p> <p><b>Settings:</b> community </p> <p><b>Intervention:</b> topical NSAID (topical diclofenac, ibuprofen, and ketoprofen gels only shown here for efficacy) </p> <p><b>Comparison:</b> topical placebo </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probable outcome with<br/> intervention</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probable outcome with<br/> comparator</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>RR, NNT, NNTp, or NNH<br/> (95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of studies, participants</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Topical diclofenac gel (as Emulgel)</b> </p> <p><b>Clinical success (eg 50% reduction in pain)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>780 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR</p> <p>3.4 (2.7 to 55)</p> <p>NNT</p> <p>1.8 (1.5 to 2.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 studies</p> <p>314 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Consistent results in 2 moderately sized recent studies of high quality</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Topical ibuprofen gel</b> </p> <p><b>Clinical success (eg 50% reduction in pain)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>420 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>160 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR</p> <p>2.7 (1.7 to 4.2)</p> <p>NNT</p> <p>3.9 (2.7 to 6.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 studies</p> <p>241 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modest effect size and numbers of participants</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Topical ketoprofen gel</b> </p> <p><b>Clinical success (eg 50% reduction in pain)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>720 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>330 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR</p> <p>2.2 (1.7 to 2.8)</p> <p>NNT</p> <p>2.5 (2.0 to 3.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 studies</p> <p>348 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modest effect size and numbers of participants, but studies small, with none recent</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All topical NSAIDs</b> </p> <p><b>Local adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR</p> <p>1.0 (0.80 to 1.2)</p> <p>NNH not calculated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42 studies</p> <p>6125 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Large number of studies and participants with consistent results</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All topical NSAIDs</b> </p> <p><b>Systemic adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR</p> <p>1.0 (0.7 to 1.3)</p> <p>NNH not calculated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38 studies</p> <p>5372 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Large number of studies and participants with consistent results</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All topical NSAIDs</b> </p> <p><b>Withdrawals ‐ adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR</p> <p>1.0 (0.7 to 1.7)</p> <p>NNH not calculated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42 studies</p> <p>5790 participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Large number of studies and participants with consistent results</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serious adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 in total</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 in total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not calculated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Small numbers of events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>CI: confidence interval; RR: risk ratio; NNT: number needed to treat for an additional beneficial outcome; NNTp: number needed to treat to prevent an event happening; NNH: number needed to treat for an additional harmful outcome. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Topical NSAIDs compared with topical placebo for acute musculoskeletal pain in adults</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/full#CD007402-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007402-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Individual NSAID versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical success <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2050</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [1.49, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>436</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.64 [1.33, 2.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Ketoprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>683</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [1.37, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Piroxicam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>504</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [1.27, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Indomethacin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [1.03, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Benzydamine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.96, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Local adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.56, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.30 [0.98, 5.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Ketoprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>852</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.83, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Piroxicam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>522</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.17, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 Felbinac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>397</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.91 [0.49, 7.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 Indomethacin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.65 [0.91, 7.73]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Individual NSAID versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007402-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Diclofenac versus placebo (effect of formulation)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical success <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2050</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [1.49, 1.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Plaster ‐ Flector</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1030</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [1.36, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Plaster ‐ other</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>474</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [1.37, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Gel ‐ Emulgel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.84 [2.68, 5.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Gel ‐ other</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [1.05, 1.27]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Diclofenac versus placebo (effect of formulation)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007402-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Ibuprofen versus placebo (effect of formulation)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical success <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>436</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.64 [1.33, 2.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Cream</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [1.03, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.66 [1.69, 4.21]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Ibuprofen versus placebo (effect of formulation)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007402-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Ketoprofen versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical success <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>683</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [1.37, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Plaster</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>335</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [1.04, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.19 [1.74, 2.75]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Ketoprofen versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007402-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">All topical NSAIDs versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Local adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6740</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.80, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Systemic adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.73, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse event withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6405</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.64, 1.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">All topical NSAIDs versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007402-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Topical NSAID versus active comparator</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical success ‐ topical piroxicam vs topical indomethacin <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>641</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [1.07, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Local adverse events ‐ topical piroxicam vs topical indomethacin <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>671</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.09, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Topical NSAID versus active comparator</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007402.pub3/references#CD007402-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007402.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD007402-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD007402-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007402-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007402-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD007402-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD007402-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD007402-note-0002">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007402\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007402\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007402\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007402\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007402\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7a2tKMcJ&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007402.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007402.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007402.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007402.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007402.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715600839"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007402.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715600845"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007402.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d8b0dbb949371',t:'MTc0MDcxNTYwMS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 